DE19746654A1 - Use of 4,4-di:aryl-butadiene derivatives as photostable UV filter compounds - Google Patents

Use of 4,4-di:aryl-butadiene derivatives as photostable UV filter compounds

Info

Publication number
DE19746654A1
DE19746654A1 DE19746654A DE19746654A DE19746654A1 DE 19746654 A1 DE19746654 A1 DE 19746654A1 DE 19746654 A DE19746654 A DE 19746654A DE 19746654 A DE19746654 A DE 19746654A DE 19746654 A1 DE19746654 A1 DE 19746654A1
Authority
DE
Germany
Prior art keywords
alkyl
cycloalkyl
compounds
cosmetic
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19746654A
Other languages
German (de)
Inventor
Thorsten Dr Habeck
Sylke Dr Haremza
Volker Dr Schehlmann
Horst Westenfelder
Thomas Dr Wuensch
Michael Dr Droegemueller
Volker Dr Bomm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Priority to DE19746654A priority Critical patent/DE19746654A1/en
Priority to ES98114967T priority patent/ES2231925T3/en
Priority to DE59812214T priority patent/DE59812214D1/en
Priority to EP98114967A priority patent/EP0916335B1/en
Priority to US09/133,173 priority patent/US6238649B1/en
Priority to AU79977/98A priority patent/AU748711B2/en
Priority to JP22888398A priority patent/JP3964989B2/en
Priority to CNB981205585A priority patent/CN1271988C/en
Publication of DE19746654A1 publication Critical patent/DE19746654A1/en
Priority to US09/765,624 priority patent/US6545174B2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • A61Q1/04Preparations containing skin colorants, e.g. pigments for lips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/618Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety having unsaturation outside the six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers

Abstract

The use of 4,4-diaryl-butadiene derivatives of formula (I), in which the diene system has Z,Z-, Z,E-, E,Z- or Z,Z-configuration (or a mixture of these), is claimed as photostable ultraviolet (UV) stabilisers in cosmetic or pharmaceutical preparations for protecting human skin against sunlight, (I) optionally being used in combination with known UV absorbers. R1,R2 = H; 1-20C alkyl, 2-10C alkenyl, 3-10C cycloalkyl, 3-10C cycloalkenyl, 1-12C alkoxy, 1-20C alkoxycarbonyl, mono- or di-(1-12C alkyl)-amino, aryl or heteroaryl (all optionally substituted); or water-solubilising substituents selected from carboxylate, sulphonate and ammonium; R3 = H or (all optionally substituted) COOR5, COR5, CONR5R6, CN, SO2R5, SO2OR5, P(O)(OR7)(OR8), 1-20C alkyl, 2-10C alkenyl, 3-10C cycloalkyl, 7-10C bicycloalkyl, 3-10C cycloalkenyl, 7-10C bicycloalkenyl, aryl or heteroaryl; R4 = as R3 but not H; R5-R8 = H or (all optionally substituted) 1-20C alkyl, 2-10C alkenyl, 3-10C cycloalkyl, 7-10C bicycloalkyl, 3-10C cycloalkenyl, 7-10C bicycloalkenyl, aryl or heteroaryl; or groups R3-R8 can together complete a 5- or 6-membered ring (optionally further fused). Also claimed are : (i) the use of (I) as photostable UV-A filters; (ii) the use of (I) as UV stabilisers in cosmetic and pharmaceutical compositions; (iii) cosmetic or pharmaceutical compositions for protecting the human epidermis or hair against UV light in the 280-400 nm region, comprising (I) and optionally known UV absorbers in a suitable carrier; (iv) (I) for use as medicament; and (v) pharmaceutical preparations containing (I).

Description

Die Erfindung betrifft die Verwendung von 4,4-Diarylbutadienen als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen zum Schutz der menschlichen Epidermis oder mensch­ liche Haare gegen UV-Strahlung, speziell im Bereich von 320 bis 400 nm.The invention relates to the use of 4,4-diarylbutadienes as photostable UV filters in cosmetic and pharmaceutical Preparations for the protection of the human epidermis or human Liche hair against UV radiation, especially in the range from 320 to 400 nm.

Die in kosmetischen und pharmazeutischen Zubereitungen eingesetz­ ten Lichtschutzmittel haben die Aufgabe, schädigende Einflüsse des Sonnenlichts auf die menschliche Haut zu verhindern oder zu­ mindest in ihren Auswirkungen zu reduzieren. Daneben dienen diese Lichtschutzmittel aber auch dem Schutz weiterer Inhaltsstoffe vor Zerstörung oder Abbau durch UV-Strahlung. In haarkosmetischen Formulierungen soll eine Schädigung der Keratinfaser durch UV-Strahlen vermindert werden.Used in cosmetic and pharmaceutical preparations th light stabilizers have the task of damaging influences to prevent or prevent sunlight from reaching human skin at least to reduce their effects. In addition, these serve Light stabilizers but also the protection of other ingredients Destruction or degradation by UV radiation. In hair cosmetic Formulations are said to cause damage to the keratin fiber UV rays are reduced.

Das an die Erdoberfläche gelangende Sonnenlicht hat einen Anteil UV-B- (280 bis 320 nm) und an UV-A-Strahlung (<320 nm), wel­ che sich direkt an den Bereich des sichtbaren Lichtes anschlie­ ßen. Der Einfluß auf die menschliche Haut macht sich besonders bei der UV-B-Strahlung durch Sonnenbrand bemerkbar. Dementspre­ chend bietet die Industrie eine größere Zahl von Substanzen an, welche die UV-B-Strahlung absorbieren und damit den Sonnenbrand verhindern.The sunlight reaching the surface of the earth has a share UV-B (280 to 320 nm) and UV-A radiation (<320 nm), wel surface directly adjoins the area of visible light eat. The influence on human skin is special Noticeable in UV-B radiation through sunburn. Dementspre Accordingly, the industry offers a larger number of substances which absorb UV-B radiation and thus sunburn impede.

Nun haben dermatologische Untersuchungen gezeigt, daß auch die UV-A-Strahlung durchaus Hautschädigungen und Allergien her­ vorrufen kann, indem beispielsweise das Keratin oder Elastin ge­ schädigt wird. Hierdurch werden Elastizität und Wasserspeicher­ vermögen der Haut reduziert, d. h. die Haut wird weniger geschmei­ dig und neigt zur Faltenbildung. Die auffallend hohe Hautkrebs­ häufigkeit in Gegenden starker Sonneneinstrahlung zeigt, daß of­ fenbar auch Schädigungen der Erbinformationen in den Zellen durch Sonnenlicht, speziell durch UV-A-Strahlung, hervorgerufen werden. All diese Erkenntnisse lassen daher die Entwicklung effizienter Filtersubstanzen für den UV-A-Bereich notwendig erscheinen.Now dermatological studies have shown that too UV-A radiation can cause skin damage and allergies can cause, for example, the keratin or elastin ge is damaged. This creates elasticity and water storage reduced capacity of the skin, d. H. the skin is less melted dig and tends to wrinkle. The strikingly high level of skin cancer frequency in areas of strong sunlight shows that of Damage to the genetic information in the cells can also be detected Sunlight, especially caused by UV-A radiation. All these findings therefore make development more efficient Filter substances appear necessary for the UV-A range.

Es besteht ein wachsender Bedarf an Lichtschutzmitteln für kosme­ tische und pharmazeutische Zubereitungen, die vor allem als UV-A-Filter dienen können und deren Absorptionsmaxima deshalb im Be­ reich von ca. 320 bis 380 nm liegen sollten. Um mit einer mög­ lichst geringen Einsatzmenge die gewünschte Wirkung zu erzielen, sollten derartige Lichtschutzmittel zusätzlich eine hoch spezifi­ sche Extinktion aufweisen. Außerdem müssen Lichtschutzmittel für kosmetische Präparate noch eine Vielzahl weiterer Anforderungen erfüllen, beispielsweise gute Löslichkeit in kosmetischen Ölen, hohe Stabilität der mit ihnen hergestellten Emulsionen, toxikolo­ gische Unbedenklichkeit sowie geringen Eigengeruch und geringe Eigenfärbung.There is a growing need for sunscreens for kosme table and pharmaceutical preparations, mainly used as UV-A filters can serve and their absorption maxima therefore in the Be should range from approx. 320 to 380 nm. To be able to to achieve the desired effect in the smallest possible amount, such light stabilizers should also have a highly specifi have cal extinction. In addition, light stabilizers must be used for cosmetic preparations have a variety of other requirements meet, for example good solubility in cosmetic oils, high stability of the emulsions made with them, toxicolo gical harmlessness as well as low inherent odor and low Inherent color.

Eine weitere Anforderung, der Lichtschutzmittel genügen müssen, ist eine ausreichende Photostabilität. Dies ist aber mit den bis­ her verfügbaren UV-A absorbierenden Lichtschutzmitteln nicht oder nur unzureichend gewährleistet.Another requirement that light stabilizers must meet is is sufficient photostability. But this is with the up not available from UV-A absorbing sunscreens or insufficiently guaranteed.

In der französischen Patentschrift Nr. 2 440 933 wird das 4-(1,1-Dimethylethyl)-4'-methoxydibenzoylmethan als UV-A-Filter beschrieben. Es wird vorgeschlagen, diesen speziellen UV-A-Fil­ ter, der von der Firma GIVAUDAN unter der Bezeichnung "PAR- SOL 1789" verkauft wird, mit verschiedenen UV-B-Filtern zu kombi­ nieren, um die gesamten UV-Strahlen mit einer Wellenlänge von 280 bis 380 nm zu absorbieren.In French patent specification No. 2 440 933 this is 4- (1,1-Dimethylethyl) -4'-methoxydibenzoylmethane as a UV-A filter described. It is suggested to use this special UV-A-Fil ter, which is available from GIVAUDAN under the name "PAR- SOL 1789 "is sold to be combined with various UV-B filters kidneys to absorb the total UV rays with a wavelength of 280 absorb up to 380 nm.

Dieser UV-A-Filter ist jedoch, wenn er allein oder in Kombina­ tion mit UV-B-Filtern verwendet wird, photochemisch nicht bestän­ dig genug, um einen anhaltenden Schutz der Haut während eines längeren Sonnenbades zu gewährleisten, was wiederholte Anwendun­ gen in regelmäßigen und kurzen Abständen erfordert, wenn man ei­ nen wirksamen Schutz der Haut gegen die gesamten UV-Strahlen er­ zielen möchte.This UV-A filter is, however, when used alone or in combination tion is used with UV-B filters, not photochemically resistant dig enough to provide lasting skin protection during one to ensure prolonged sunbathing, resulting in repeated applications gen at regular and short intervals when using ei effective protection of the skin against all UV rays want to aim.

Deshalb sollen gemäß EP-A-0 514 491 die nicht ausreichend photo­ stabilen UV-A-Filter durch den Zusatz von 2-Cyan-3,3-diphenyla­ crylsäureestern stabilisiert werden, die selbst im UV-B-Bereich als Filter dienen.Therefore, according to EP-A-0 514 491, the insufficient photo stable UV-A filter through the addition of 2-cyan-3,3-diphenyla Acrylic acid esters are stabilized, even in the UV-B range serve as a filter.

Weiterhin wurde gemäß EP-A-0 251 398 schon vorgeschlagen, UV-A- und UV-B-Strahlung absorbierende Chromophore durch ein Bindeglied einem Molekül zu vereinen. Dies hat den Nachteil, daß einer­ seits keine freie Kombination von UV-A- und UV-B-Filtern in der kosmetischen Zubereitung mehr möglich ist und daß Schwierigkeiten bei der chemischen Verknüpfung der Chromophore nur bestimmte Kom­ binationen zulassen.Furthermore, it has already been proposed according to EP-A-0 251 398, Chromophores absorbing UV-A and UV-B radiation through a link to unite a molecule. This has the disadvantage that one on the other hand, there is no free combination of UV-A and UV-B filters in the cosmetic preparation is more possible and that difficulties in the chemical linkage of the chromophores only certain com allow binations.

US 4,950,467 beschreibt die Verwendung von 2,4-Pentadiensäurede­ rivaten als UV-Absorber in kosmetischen Präparaten. Die in dieser Patentschrift bevorzugt genannten Monoaryl-substituierten Verbin­ dungen haben ebenfalls den Nachteil, daß sie nicht genügend pho­ tostabil sind.No. 4,950,467 describes the use of 2,4-pentadienoic acid derivatives as UV absorbers in cosmetic preparations. The one in this Patent preferred monoaryl-substituted compound mentioned Applications also have the disadvantage that they do not have enough pho are extremely stable.

Es bestand daher die Aufgabe, Lichtschutzmittel für kosmetische und pharmazeutische Zwecke vorzuschlagen, die im UV-A-Bereich mit hoher Extinktion absorbieren, die photostabil sind, eine geringe Eigenfarbe d. h. eine scharfe Bandenstruktur aufweisen und je nach Substituent in Öl oder Wasser löslich sind.The object was therefore to find light stabilizers for cosmetic and to propose pharmaceutical purposes that are in the UV-A range absorb high absorbance, which are photostable, a low one Own color d. H. have a sharp band structure and depending on Substituent are soluble in oil or water.

Diese Aufgabe wurde erfindungsgemäß gelöst durch Verwendung von 4,4-Diarylbutadienen der Formel I
This object was achieved according to the invention by using 4,4-diarylbutadienes of the formula I.

in der das Diensystem in der Z,Z; Z,E; E,Z oder E,E Konfiguration oder einer Mischung davon vorliegt und in der die Variablen fol­ gende Bedeutung haben:
R1 und R2 unabhängig voneinander Wasserstoff, C1-C20-Alkyl, C2-C10-Alkenyl, C3-C10-Cycloalkyl, C3-C10-Cycloalkenyl, C1-C12-Alkoxy, C1-C20-Alkoxycarbonyl, C1-C12-Alkylamino, C1-C12-Dialkylamino, Aryl, Heteroaryl, gegebenenfalls substi­ tuiert, wasserlöslich machende Substituenten, ausgewählt aus der Gruppe bestehend aus Carboxylat-, Sulfonat- oder Ammoni­ umresten;
R3 Wasserstoff, COOR5, COR5, CONR5R6, CN, O=S(-R5)=O, O=S(-OR5)=O, R7O-P(-OR8)=O, C1-C20-Alkyl, C2-C10-Alkenyl, C3-C10-Cycloalkyl, C7-C10-Bicy­ cloalkyl, C3-C10-Cycloalkenyl, C7-C10-Bicycloalkenyl, Aryl, Heteroaryl, gegebenenfalls substituiert;
R4 COOR6, COR6, CONR5R6, CN, O=S(-R6)=O, O=S(-OR6)=O, R7O-P(-OR8)=O C1-C20-Alkyl, C2-C10-Alkenyl, C3-C10-Cycloalkyl, C7-C10-Bicyclo­ alkyl, C3-C10-Cycloalkenyl, C7-C10-Bicycloalkenyl, Aryl, Hete­ roaryl, gegebenenfalls substituiert;
R5 bis R8 unabhängig voneinander Wasserstoff, C1-C20-Alkyl, C2-C10-Alkenyl, C3-C10-Cycloalkyl, C7-C10-Bicycloalkyl, C3-C10-Cycloalkenyl, C7-C10-Bicycloalkenyl, Aryl, Heteroaryl, gegebenenfalls substituiert;
wobei die Variablen R3 bis R8 untereinander, jeweils zusammen mit Kohlenstoffatomen, an die sie gebunden sind, gemeinsam einen 5- oder 6-Ring bilden können, der gegebenenfalls weiter anelliert sein kann,
als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen zum Schutz der menschlichen Haut oder menschlicher Haare gegen Sonnenstrahlen, allein oder zusammen mit an sich für kosmetische und pharmazeutische Zubereitungen bekannten, im UV-Bereich absorbierenden Verbindungen.
in which the diene system in the Z, Z; Z, E; E, Z or E, E configuration or a mixture thereof is present and in which the variables have the following meanings:
R 1 and R 2 independently of one another are hydrogen, C 1 -C 20 -alkyl, C 2 -C 10 -alkenyl, C 3 -C 10 -cycloalkyl, C 3 -C 10 -cycloalkenyl, C 1 -C 12 -alkoxy, C 1 -C 20 alkoxycarbonyl, C 1 -C 12 alkylamino, C 1 -C 12 dialkylamino, aryl, heteroaryl, optionally substituted, water-solubilizing substituents selected from the group consisting of carboxylate, sulfonate or ammonium radicals;
R 3 hydrogen, COOR 5 , COR 5 , CONR 5 R 6 , CN, O = S (-R 5 ) = O, O = S (-OR 5 ) = O, R 7 OP (-OR 8 ) = O, C 1 -C 20 alkyl, C 2 -C 10 alkenyl, C 3 -C 10 cycloalkyl, C 7 -C 10 bicloalkyl, C 3 -C 10 cycloalkenyl, C 7 -C 10 bicycloalkenyl, aryl , Heteroaryl, optionally substituted;
R 4 COOR 6 , COR 6 , CONR 5 R 6 , CN, O = S (-R 6 ) = O, O = S (-OR 6 ) = O, R 7 OP (-OR 8 ) = OC 1 -C 20 alkyl, C 2 -C 10 alkenyl, C 3 -C 10 cycloalkyl, C 7 -C 10 bicyclo alkyl, C 3 -C 10 cycloalkenyl, C 7 -C 10 bicycloalkenyl, aryl, heteroaryl, optionally substituted;
R 5 to R 8 independently of one another are hydrogen, C 1 -C 20 alkyl, C 2 -C 10 alkenyl, C 3 -C 10 cycloalkyl, C 7 -C 10 bicycloalkyl, C 3 -C 10 cycloalkenyl, C 7 -C 10 -bicycloalkenyl, aryl, heteroaryl, optionally substituted;
where the variables R 3 to R 8 with one another, in each case together with carbon atoms to which they are bonded, can together form a 5- or 6-ring, which can optionally be further fused,
as photostable UV filters in cosmetic and pharmaceutical preparations for protecting the human skin or human hair against sun rays, alone or together with compounds which are known per se for cosmetic and pharmaceutical preparations and absorb in the UV range.

Als Alkylreste R1 bis R8 seien verzweigte oder unverzweigte C1-C20-Alkylketten, bevorzugt Methyl, Ethyl, n-Propyl, 1-Methyl­ ethyl, n-Butyl, 1-Methylpropyl-, 2-Methylpropyl, 1,1-Dimethyl­ ethyl, n-Pentyl, 1-Methylbutyl, 2-Methylbutyl, 3-Methylbutyl, 2,2-Dimethylpropyl, 1-Ethylpropyl, n-Hexyl, 1,1-Dimethylpropyl, 1,2-Dimethylpropyl, 1-Methylpentyl, 2-Methylpentyl, 3-Methyl­ pentyl, 4-Methylpentyl, 1,1-Dimethylbutyl, 1,2-Dimethylbutyl, 1,3-Dimethylbutyl, 2,2-Dimethylbutyl, 2,3-Dimethylbutyl, 3,3-Dimethylbutyl, 1-Ethylbutyl, 2-Ethylbutyl, 1,1,2-Trimethyl­ propyl, 1,2,2-Trimethylpropyl, 1-Ethyl-1-methylpropyl, 1-Ethyl-2-methylpropyl, n-Heptyl, n-Octyl, n-Nonyl, n-Decyl, n-Undecyl, n-Dodecyl, n-Tridecyl, n-Tetradecyl, n-Pentadecyl, n-Hexadecyl, n-Heptadecyl, n-Octadecyl, n-Nonadecyl oder n-Eico­ syl genannt.As alkyl radicals R 1 to R 8 , branched or unbranched C 1 -C 20 -alkyl chains, preferably methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1- Dimethyl ethyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2 -Methylpentyl, 3-methyl pentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1- Ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, n-heptyl, n-octyl, n-nonyl , n-decyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl or n-eico syl.

Als Alkenylreste R1 bis R8 seien verzweigte oder unverzweigte C2-C10-Alkenylketten, bevorzugt Vinyl, Propenyl, Isopropenyl, 1-Butenyl, 2-Butenyl, 1-Pentenyl, 2-Pentenyl, 2-Methyl-1-butenyl, 2-Methyl-2-butenyl, 3-Methyl-1-butenyl, 1-Hexenyl, 2-Hexenyl, 1-Heptenyl, 2-Heptenyl, 1-Octenyl oder 2-Octenyl genannt.Alkenyl radicals R 1 to R 8 are branched or unbranched C 2 -C 10 alkenyl chains, preferably vinyl, propenyl, isopropenyl, 1-butenyl, 2-butenyl, 1-pentenyl, 2-pentenyl, 2-methyl-1-butenyl, 2-methyl-2-butenyl, 3-methyl-1-butenyl, 1-hexenyl, 2-hexenyl, 1-heptenyl, 2-heptenyl, 1-octenyl or 2-octenyl.

Als Cycloalkylreste seien für R1 bis R8 bevorzugt verzweigte oder unverzweigte C3-C10-Cycloalkylketten wie Cyclopropyl, Cyclobutyl, Cyclopentyl, Cyclohexyl, Cycloheptyl, 1-Methylcyclopropyl, 1-Ethylcyclopropyl, 1-Propylcyclopropyl, 1-Butylcyclopropyl, 1-Pentylcyclopropyl, 1-Methyl-1-Butylcyclopropyl, 1,2-Dimethylcy­ clypropyl, 1-Methyl-2-Ethylcyclopropyl, Cyclooctyl, Cyclononyl oder Cyclodecyl genannt.Preferred cycloalkyl radicals for R 1 to R 8 are branched or unbranched C 3 -C 10 cycloalkyl chains such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, 1-methylcyclopropyl, 1-ethylcyclopropyl, 1-propylcyclopropyl, 1-butylcyclopropyl, 1-butylcyclopropyl, , 1-methyl-1-butylcyclopropyl, 1,2-dimethylcyclypropyl, 1-methyl-2-ethylcyclopropyl, cyclooctyl, cyclononyl or cyclodecyl called.

Als Cycloalkenylreste seien für R1 bis R8 bevorzugt verzweigte oder unverzweigte, C3-C10-Cycloalkenylketten mit einer oder mehre­ ren Doppelbindungen wie Cyclopropenyl, Cyclobutenyl, Cyclopente­ nyl, Cyclopentadienyl, Cyclohexenyl, 1,3-Cyclohexadienyl, 1,4-Cy­ clohexadienyl, Cycloheptenyl, Cycloheptatrienyl, Cyclooctenyl, 1,5-Cyclooctadienyl, Cyclooctatetraenyl, Cyclononenyl oder Cyclo­ decyl genannt.Preferred cycloalkenyl radicals for R 1 to R 8 are branched or unbranched, C 3 -C 10 cycloalkenyl chains with one or more double bonds, such as cyclopropenyl, cyclobutenyl, cyclopentene nyl, cyclopentadienyl, cyclohexenyl, 1,3-cyclohexadienyl, 1,4-cy clohexadienyl, cycloheptenyl, cycloheptatrienyl, cyclooctenyl, 1,5-cyclooctadienyl, cyclooctatetraenyl, cyclononenyl or cyclo decyl called.

Die Cycloalkenyl- und Cycloalkylreste können ggf. mit einem oder mehreren, z. B. 1 bis 3 Resten wie Halogen z. B. Fluor, Chlor oder Brom, Cyano, Nitro, Amino, C1-C4-Alkylamino, C1-C4-Dialkylamino, Hydroxy, C1-C4-Alkyl, C1-C4-Alkoxy oder anderen Resten substi­ tuiert sein oder 1 bis 3 Heteroatome wie Schwefel, Stickstoff, dessen freie Valenzen durch Wasserstoff oder C1-C4-Alkyl abgesät­ tigt sein können oder Sauerstoff im Ring enthalten.The cycloalkenyl and cycloalkyl radicals can optionally with one or more, z. B. 1 to 3 radicals such as halogen z. B. fluorine, chlorine or bromine, cyano, nitro, amino, C 1 -C 4 -alkylamino, C 1 -C 4 -dialkylamino, hydroxy, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy or other radicals be substituted or 1 to 3 heteroatoms such as sulfur, nitrogen, the free valences of which can be saturated by hydrogen or C 1 -C 4 -alkyl or contain oxygen in the ring.

Als Bicycloalkyl- oder Bicycloalkenylreste seien für R3 bis R8 ge­ sättigte oder ungesättigte C7-C10 bicyclische Ringsysteme, insbe­ sondere bicyclische Terpene wie Pinan-, Pinen-, Bornan-, Campher­ derivate oder auch Adamantan genannt.As bicycloalkyl or bicycloalkenyl radicals for R 3 to R 8 are ge saturated or unsaturated C 7 -C 10 bicyclic ring systems, in particular special bicyclic terpenes such as pinane, pinene, bornane, camphor derivatives or adamantane.

Als Alkoxyreste für R1 und R2 kommen solche mit 1 bis 12 C-Atomen, vorzugsweise mit 1 bis 8 C-Atomen in Betracht.Suitable alkoxy radicals for R 1 and R 2 are those with 1 to 12 carbon atoms, preferably with 1 to 8 carbon atoms.

Beispielsweise sind zu nennen:
Examples include:

Methoxy-Methoxy Ethoxy-Ethoxy Isopropoxy-Isopropoxy n-Propoxy-n-propoxy 1-Methylpropoxy-1-methylpropoxy n-Butoxy-n-butoxy n-Pentoxy-n-pentoxy 2-Methylpropoxy-2-methylpropoxy 3-Methylbutoxy-3-methylbutoxy 1,1-Dimethylpropoxy-1,1-dimethylpropoxy 2,2-Dimethylpropoxy-2,2-dimethylpropoxy Hexoxy-Hexoxy 1-Methyl-1-ethylpropoxy-1-methyl-1-ethylpropoxy Heptoxy-Heptoxy Octoxy-Octoxy 2-Ethylhexoxy-2-ethylhexoxy

Alkoxycarbonylreste für R1 und R2 sind z. B. Ester, die die oben ge­ nannten Alkoxyreste oder Reste von höheren Alkoholen z. B. mit bis 20 C-Atomen, wie iso-C15-Alkohol, enthalten.Alkoxycarbonyl radicals for R 1 and R 2 are, for. B. esters containing the above-mentioned alkoxy radicals or radicals of higher alcohols z. B. with up to 20 carbon atoms, such as iso-C 15 alcohol.

Als Mono- oder Dialkylaminoreste für R1 und R2 kommen solche in Betracht, die Alkylreste mit 1 bis 12 C-Atomen enthalten, wie z. B. Methyl-, n-Propyl-, n-Butyl-, 2-Methylpropyl-, 1,1-Dimethyl­ propyl-, Hexyl-, Heptyl-, 2-Ethylhexyl-, Isopropyl-, 1-Methylpro­ pyl-, n-Pentyl-, 3-Methylbutyl-, 2,2-Dimethylpropyl-, 1-Me­ thyl-1-ethylpropyl- und Octyl.Suitable mono- or dialkylamino radicals for R 1 and R 2 are those which contain alkyl radicals having 1 to 12 carbon atoms, such as. B. methyl, n-propyl, n-butyl, 2-methylpropyl, 1,1-dimethyl propyl, hexyl, heptyl, 2-ethylhexyl, isopropyl, 1-methylpro pyl, n- Pentyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-methyl-1-ethylpropyl and octyl.

Unter Aryl sind aromatische Ringe oder Ringsysteme mit 6 bis 18 Kohlenstoffatomen im Ringsystem zu verstehen, beispielsweise Phenyl oder Naphthyl, die ggf. mit einem oder mehreren Resten wie Halogen z. B. Fluor, Chlor oder Brom, Cyano, Nitro, Amino, C1-C4-Alkylamino, C1-C4-Dialkylamino, Hydroxy, C1-C4-Alkyl, C1-C4-Alkoxy oder anderen Resten substituiert sein können. Bevor­ zugt sind ggf. substituiertes Phenyl, Methoxyphenyl und Naphthyl.Aryl is to be understood as meaning aromatic rings or ring systems with 6 to 18 carbon atoms in the ring system, for example phenyl or naphthyl, optionally with one or more radicals such as halogen, for. B. fluorine, chlorine or bromine, cyano, nitro, amino, C 1 -C 4 -alkylamino, C 1 -C 4 -dialkylamino, hydroxy, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy or other radicals can be substituted. Any substituted phenyl, methoxyphenyl and naphthyl are preferred.

Heteroaryl-Reste sind vorteilhafterweise einfache oder konden­ sierte aromatische Ringsysteme mit einem oder mehreren heteroaro­ matischen 3- bis 7gliedrigen Ringen. Als Heteroatome können ein oder mehrere Stickstoff-, Schwefel- und/oder Sauerstoffatome im Ring oder Ringsystem enthalten sein.Heteroaryl radicals are advantageously simple or condensed based aromatic ring systems with one or more heteroaro matic 3- to 7-membered rings. As heteroatoms can be a or more nitrogen, sulfur and / or oxygen atoms in the Ring or ring system be included.

Hydrophile d. h. die Wasserlöslichkeit der Verbindungen der Formel ermöglichende Reste für R1 und R2 sind z. B. Carboxy- und Sulfo­ xyreste und insbesondere deren Salze mit beliebigen physiologisch verträglichen Kationen, wie die Alkalisalze oder wie die Trialkyl­ ammoniumsalze, wie Tri-(hydroxyalkyl)-ammoniumsalze oder die 2-Methylpropan-1-ol-2-ammoniumsalze. Ferner kommen Ammonium-, insbesondere Alkylammoniumreste mit beliebigen physiologisch ver­ träglichen Anionen in Betracht.Hydrophilic, ie the water solubility of the compounds of the formula enabling radicals for R 1 and R 2 are z. B. carboxy and sulfo xyreste and especially their salts with any physiologically acceptable cations, such as the alkali salts or the trialkyl ammonium salts, such as tri- (hydroxyalkyl) ammonium salts or the 2-methylpropan-1-ol-2-ammonium salts. Ammonium, in particular alkylammonium, radicals with any physiologically acceptable anions are also suitable.

Bevorzugt sind solche Verbindungen der Formel I, in der
R1 und R2 unabhängig voneinander Wasserstoff, C1-C12-Alkyl, C1-C8-Alkoxy, C1-C12-Alkylamino, C1-C12-Dialkylamino, wasserlöslich machende Substituenten, ausgewählt aus der Gruppe bestehend aus Carboxylat-, Sulfonat- oder Ammoniumre­ sten;
R3 Wasserstoff, COOR5, COR5, CONR5R6, CN, C1-C12-Alkyl, C3-C6-Cycloalkyl, C7-C10-Bicycloalkyl, Phenyl, Naphthyl, Thienyl, gegebenenfalls substituiert;
R4 COOR6, COR6, CONR5R6, CN, C1-C12-Alkyl, C3-C10-Cycloalkyl, C7-C10-Bicycloalkyl, Phenyl, Naphthyl, Thienyl, gegebenenfalls substituiert;
R5 und R6 unabhängig voneinander Wasserstoff, C1-C12-Alkyl, C3-C6-Cycloalkyl, C7-C10-Bicycloalkyl, Phenyl, Naphthyl, gegebenenfalls substituiert,
bedeutet.
Those compounds of the formula I are preferred in which
R 1 and R 2 independently of one another are hydrogen, C 1 -C 12 -alkyl, C 1 -C 8 -alkoxy, C 1 -C 12 -alkylamino, C 1 -C 12 -dialkylamino, water-solubilizing substituents selected from the group consisting of from carboxylate, sulfonate or ammonium residues;
R 3 is hydrogen, COOR 5 , COR 5 , CONR 5 R 6 , CN, C 1 -C 12 alkyl, C 3 -C 6 cycloalkyl, C 7 -C 10 bicycloalkyl, phenyl, naphthyl, thienyl, optionally substituted;
R 4 COOR 6 , COR 6 , CONR 5 R 6 , CN, C 1 -C 12 alkyl, C 3 -C 10 cycloalkyl, C 7 -C 10 bicycloalkyl, phenyl, naphthyl, thienyl, optionally substituted;
R 5 and R 6 independently of one another are hydrogen, C 1 -C 12 alkyl, C 3 -C 6 cycloalkyl, C 7 -C 10 bicycloalkyl, phenyl, naphthyl, optionally substituted,
means.

Als C1-C12-Alkylreste seien für R1 bis R6 besonders bevorzugt Methyl, Ethyl, n-Propyl, 1-Methylethyl, n-Butyl, 1-Methylpropyl-, 2-Methylpropyl, 1,1-Dimethylethyl, n-Pentyl, 1-Methylbutyl, 2-Methylbutyl, 3-Methylbutyl, 2,2-Dimethylpropyl, 2-Ethylhexyl genannt. Particularly preferred C 1 -C 12 -alkyl radicals for R 1 to R 6 are methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, n- Pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 2-ethylhexyl.

Als Cycloalkylreste seien für R3 bis R6 besonders bevorzugt ver­ zweigtes oder unverzweigtes Cyclopentyl und Cyclohexyl genannt.As cycloalkyl radicals for R 3 to R 6 , branched or unbranched cyclopentyl and cyclohexyl are particularly preferred.

Als Mono- oder Dialkylaminoreste kommen für R1 und R2 besonders bevorzugt Methyl-, Ethyl-, n-Propyl-, n-Butyl-, 2-Methylpropyl-, 1,1-Dimethylpropyl-, 2-Ethylhexyl in Betracht.Particularly preferred mono- or dialkylamino radicals for R 1 and R 2 are methyl, ethyl, n-propyl, n-butyl, 2-methylpropyl, 1,1-dimethylpropyl, 2-ethylhexyl.

Als Bicycloalkylreste seien für R3 bis R6 besonders bevorzugt Cam­ pherderivate genannt.Particularly preferred bicycloalkyl radicals for R 3 to R 6 are cam pher derivatives.

Die Substituenten R1 und R2 können jeweils in ortho, meta oder para Position am Aromaten gebunden sein. Besonders bevorzugt sind Verbindungen der Formel I, in denen R1 gleich R2 ist und beide Re­ ste in der para-Position vorliegen.The substituents R 1 and R 2 can each be bonded to the aromatic in the ortho, meta or para position. Particularly preferred are compounds of the formula I in which R 1 is the same as R 2 and both Re ste are in the para position.

Besonders bevorzugt ist weiterhin die Verwendung von Verbindungen der Formel I, in der R3 oder R4 nicht H, CN, C1-C20-Alkyl, C2-C10-Alkenyl, Aryl, Heteroaryl, gegebenenfalls substituiert, sein darf, wenn R4 bzw. R3 COOR5 oder COOR6 bedeutet.The use of compounds of the formula I in which R 3 or R 4 may not be H, CN, C 1 -C 20 -alkyl, C 2 -C 10 -alkenyl, aryl, heteroaryl, optionally substituted, is also particularly preferred, when R 4 or R 3 is COOR 5 or COOR 6 .

Ganz besonders bevorzugt sind solche Verbindungen der Formel I, der
R1 und R2 unabhängig voneinander Wasserstoff, C1-C12-Alkyl, C1-C8-Alkoxy, wasserlöslich machende Substituenten, ausgewählt aus der Gruppe bestehend aus Carboxylat-, Sulfonat- oder Am­ moniumresten;
R3 Wasserstoff, COOR5, COR5, CONR5R6, CN, C3-C6-Cycloalkyl, C7-C10-Bicycloalkyl;
R4 COOR6, COR6, CONR5R6, CN, C3-C6-Cycloalkyl, C7-C10-Bicycloalkyl,
wobei R3 oder R4 nicht COOR5 oder COOR6 sein darf, wenn R4 CN bzw. R3 Wasserstoff oder CN ist;
R5 und R6 unabhängig voneinander Wasserstoff, C1-C12-Alkyl, C3-C6-Cycloalkyl, C7-C10-Bicycloalkyl, Phenyl, Naphthyl, gegebenenfalls substituiert,
bedeutet.
Compounds of the formula I are very particularly preferred
R 1 and R 2 independently of one another are hydrogen, C 1 -C 12 -alkyl, C 1 -C 8 -alkoxy, water-solubilizing substituents selected from the group consisting of carboxylate, sulfonate or ammonium radicals;
R 3 is hydrogen, COOR 5 , COR 5 , CONR 5 R 6 , CN, C 3 -C 6 cycloalkyl, C 7 -C 10 bicycloalkyl;
R 4 COOR 6 , COR 6 , CONR 5 R 6 , CN, C 3 -C 6 cycloalkyl, C 7 -C 10 bicycloalkyl,
where R 3 or R 4 may not be COOR 5 or COOR 6 when R 4 is CN or R 3 is hydrogen or CN;
R 5 and R 6 independently of one another are hydrogen, C 1 -C 12 alkyl, C 3 -C 6 cycloalkyl, C 7 -C 10 bicycloalkyl, phenyl, naphthyl, optionally substituted,
means.

Weiterhin weisen Verbindungen der Formel I besondere photostabile Eigenschaften aus, bei denen die Substituenten R1 bis R4 in der in Tabelle 1 genannten Kombination vorliegen: Furthermore, compounds of the formula I have particular photostable properties in which the substituents R 1 to R 4 are present in the combination specified in Table 1:

Tabelle 1 Table 1

Ebenfalls ganz besonders bevorzugt sind solche Verbindungen der Formel I, die besonders photostabil und gleichzeitig farblos sind, in der
R1 und R2 unabhängig voneinander Wasserstoff, C1-C12-Alkyl, C1-C8-Alkoxy, wasserlöslich machende Substituenten, ausgewählt aus der Gruppe bestehend aus Carboxylat-, Sulfonat- oder Am­ moniumresten;
R3 COOR5, COR5, CONR5R6;
R4 COOR6, COR6, CONR5R6;
R5 und R6 unabhängig voneinander Wasserstoff, C1-C12-Alkyl, C3-C6-Cycloalkyl, C7-C10-Bicycloalkyl, Phenyl, Naphthyl, gegebenenfalls substituiert,
bedeutet.
Likewise very particularly preferred are those compounds of the formula I which are particularly photostable and at the same time colorless, in which
R 1 and R 2 independently of one another are hydrogen, C 1 -C 12 -alkyl, C 1 -C 8 -alkoxy, water-solubilizing substituents selected from the group consisting of carboxylate, sulfonate or ammonium radicals;
R 3 COOR 5 , COR 5 , CONR 5 R 6 ;
R 4 COOR 6 , COR 6 , CONR 5 R 6 ;
R 5 and R 6 independently of one another are hydrogen, C 1 -C 12 alkyl, C 3 -C 6 cycloalkyl, C 7 -C 10 bicycloalkyl, phenyl, naphthyl, optionally substituted,
means.

Die erfindungsgemäß zu verwendenden Verbindungen der Formel I können nach der Gleichung
The compounds of the formula I to be used according to the invention can be prepared according to the equation

durch Kondensation hergestellt werden, wobei R1 bis R4 die im An­ spruch 1 genannte Bedeutung haben. be prepared by condensation, where R 1 to R 4 have the meaning given in claim 1 to.

Beispielsweise ergibt die Umsetzung von β-Phenylzimtaldehyd mit Malonsäurediethylester die Verbindung 1 in Tab. 2.For example, the reaction of β-phenylcinnamaldehyde results in Diethyl malonate is compound 1 in Tab. 2.

Für den Fall, daß R3≠R4, können die erfindungsgemäßen Verbindun­ gen der Formel I prinzipiell in ihren verschiedenen geometrischen Isomeren, d. h. mit einem Z,Z; Z,E; E,Z und/oder E,E-konfigurier­ ten Diensystem, vorliegen. Bevorzugt als kosmetische Lichtschutz­ mittel sind die all-E- und/oder all-Z-Isomeren, ganz besonders bevorzugt sind die all-E-Isomeren.In the event that R 3 ≠ R 4 , the compounds according to the invention of the formula I can in principle in their various geometric isomers, ie with a Z, Z; Z, E; E, Z and / or E, E-configured diene system are present. The all-E and / or all-Z isomers are preferred as cosmetic light protection agents, the all-E isomers are very particularly preferred.

Ist R3 = R4, so kann die C-C Doppelbindung zwischen C-3 und C-4 (in Nachbarstellung zum Diarylsystem) in der E- und/oder Z-Konfi­ guration, bevorzugt in der Z-Konfiguration vorliegen.If R 3 = R 4 , the CC double bond between C-3 and C-4 (in the position adjacent to the diaryl system) can be in the E and / or Z configuration, preferably in the Z configuration.

Die Lichtschutzmittel enthaltenden kosmetischen und pharmazeuti­ schen Zubereitungen sind in der Regel auf der Basis eines Trä­ gers, der mindestens eine Ölphase enthält. Es sind aber auch Zu­ bereitungen allein auf wäßriger Basis bei Verwendung von Verbin­ dungen mit hydrophilen Substituenten möglich. Demgemäß kommen Öle, Öl-in-Wasser- und Wasser-in-Öl-Emulsionen, Cremes und Pa­ sten, Lippenschutzstiftmassen oder fettfreie Gele in Betracht.The cosmetic and pharmaceutical products containing light stabilizers cal preparations are usually based on a Trä gers, which contains at least one oil phase. But they are also closed preparations on an aqueous basis only when using Verbin Applications with hydrophilic substituents are possible. Come accordingly Oils, oil-in-water and water-in-oil emulsions, creams and pa sten, lip protection stick masses or fat-free gels into consideration.

Solche Sonnenschutzpräparate können demgemäß in flüssiger, pastö­ ser oder fester Form vorliegen, beispielsweise als Wasser-in-Öl-Cremes, Öl-in-Wasser-Cremes und -Lotionen, Aerosol-Schaumcremes, Gele, Öle, Fettstifte, Puder, Sprays oder alkoholisch-wäßrige Lo­ tionen.Such sunscreen preparations can accordingly be liquid, pasty in water or solid form, for example as water-in-oil creams, Oil-in-water creams and lotions, aerosol foam creams, Gels, oils, grease pencils, powders, sprays or alcohol-based loos options.

Übliche Ölkomponenten in der Kosmetik sind beispielsweise Paraf­ finöl, Glycerylstearat, Isopropylmyristat, Diisopropyladipat, 2-Ethylhexansäurecetylstearylester, hydriertes Polyisobuten, Va­ seline, Caprylsäure/Caprinsäure-Triglyceride, mikrokristallines Wachs, Lanolin und Stearinsäure.Common oil components in cosmetics are, for example, paraf fin oil, glyceryl stearate, isopropyl myristate, diisopropyl adipate, Cetylstearyl 2-ethylhexanoate, hydrogenated polyisobutene, Va seline, caprylic acid / capric acid triglycerides, microcrystalline Wax, lanolin and stearic acid.

Übliche kosmetische Hilfsstoffe, die als Zusätze in Betracht kom­ men können, sind z. B. Co-Emulgatoren, Fette und Wachse, Stabili­ satoren, Verdickungsmittel, biogene Wirkstoffe, Filmbildner, Duftstoffe, Farbstoffe, Perlglanzmittel, Konservierungsmittel, Pigmente, Elektrolyte (z. B. Magnesiumsulfat) und pH-Regulatoren. Als Co-Emulgatoren kommen vorzugsweise bekannte W/O- und daneben auch O/W-Emulgatoren wie etwa Polyglycerinester, Sorbitanester oder teilveresterte Glyceride in Betracht. Typische Beispiele für Fette sind Glyceride; als Wachse sind u. a. Bienenwachs, Paraffin­ wachs oder Mikrowachse gegebenenfalls in Kombination mit hydro­ philen Wachsen zu nennen. Als Stabilisatoren können Metallsalze Fettsäuren wie z. B. Magnesium-, Aluminium- und/oder Zinkstea­ rat eingesetzt werden. Geeignete Verdickungsmittel sind bei­ spielsweise vernetzte Polyacrylsäuren und deren Derivate, Poly­ saccharide, insbesondere Xanthan-Gum, Guar-Guar, Agar-Agar, Algi­ nate und Tylosen, Carboxymethylcellulose und Hydroxyethylcellu­ lose, ferner Fettalkohole, Monoglyceride und Fettsäuren, Polycry­ late, Polyvinylalkohol und Polyvinylpyrrolidon. Unter biogenen Wirkstoffen sind beispielsweise Pflanzenextrakte, Eiweißhydroly­ sate und Vitaminkomplexe zu verstehen. Gebräuchliche Filmbildner sind beispielsweise Hydrocolloide wie Chitosan, mikrokristallines Chitosan oder quaterniertes Chitosan, Polyvinylpyrrolidon, Vinyl­ pyrrolidon-Vinylacetat-Copolymerisate, Polymere der Acrylsäure­ reihe, quaternäre Cellulose-Derivate und ähnliche Verbindungen. Als Konservierungsmittel eignen sich beispielsweise Formaldehyd­ lösung, p-Hydroxybenzoat oder Sorbinsäure. Als Perlglanzmittel kommen beispielsweise Glycoldistearinsäureester wie Ethylengly­ coldistearat, aber auch Fettsäuren und Fettsäuremonoglycolester in Betracht. Als Farbstoffe können die für kosmetische Zwecke ge­ eigneten und zugelassenen Substanzen verwendet werden, wie sie beispielsweise in der Publikation "Kosmetische Färbemittel" der Farbstoffkoimmission der Deutschen Forschungsgemeinschaft, veröf­ fentlicht im Verlag Chemie, Weinheim, 1984, zusammengestellt sind. Diese Farbstoffe werden üblicherweise in Konzentration von 0,001 bis 0,1 Gew.-%, bezogen auf die gesamte Mischung, einge­ setzt.Usual cosmetic auxiliaries that can be used as additives men are z. B. co-emulsifiers, fats and waxes, stabilizers agents, thickeners, biogenic agents, film formers, Fragrances, dyes, pearlescent agents, preservatives, Pigments, electrolytes (e.g. magnesium sulfate) and pH regulators. Known W / O and in addition are preferably used as co-emulsifiers also O / W emulsifiers such as polyglycerol esters, sorbitan esters or partially esterified glycerides. Typical examples of Fats are glycerides; as waxes are inter alia. Beeswax, paraffin wax or micro waxes, optionally in combination with hydro phile waxes. Metal salts can be used as stabilizers Fatty acids such as B. magnesium, aluminum and / or zinc stea council are used. Suitable thickeners are at for example crosslinked polyacrylic acids and their derivatives, poly saccharides, in particular xanthan gum, guar guar, agar agar, algi nate and tylose, carboxymethyl cellulose and hydroxyethyl cellulose loose, also fatty alcohols, monoglycerides and fatty acids, polycry late, polyvinyl alcohol and polyvinyl pyrrolidone. Under biogenic Active ingredients are, for example, plant extracts, protein hydrolytes To understand sate and vitamin complexes. Common film formers are for example hydrocolloids such as chitosan, microcrystalline Chitosan or quaternized chitosan, polyvinylpyrrolidone, vinyl pyrrolidone-vinyl acetate copolymers, polymers of acrylic acid series, quaternary cellulose derivatives and similar compounds. Formaldehyde, for example, is suitable as a preservative solution, p-hydroxybenzoate or sorbic acid. As a pearlescent agent for example glycol distearic acid esters such as ethylene glycol cold distearate, but also fatty acids and fatty acid monoglycol esters into consideration. As dyes, those used for cosmetic purposes can be used Appropriate and approved substances are used as they are for example in the publication "Cosmetic colorants" Dye Coordination of the German Research Foundation, publ published by Verlag Chemie, Weinheim, 1984, compiled are. These dyes are usually used in concentrations of 0.001 to 0.1 wt .-%, based on the total mixture, incorporated puts.

Der Gesamtanteil der Hilfs- und Zusatzstoffe kann 1 bis 80, vor­ zugsweise 6 bis 40 Gew.-% und der nicht wäßrige Anteil ("Aktiv­ substanz") 20 bis 80, vorzugsweise 30 bis 70 Gew.-% - bezogen auf die Mittel - betragen. Die Herstellung der Mittel kann in an sich bekannter Weise, d. h. beispielsweise durch Heiß-, Kalt-, Heiß-Heiß/Kalt- bzw. PIT-Emulgierung erfolgen. Hierbei handelt es sich um ein rein mechanisches Verfahren, eine chemische Reaktion fin­ det nicht statt.The total amount of auxiliaries and additives can be 1 to 80, before preferably 6 to 40% by weight and the non-aqueous portion ("Aktiv substance ") 20 to 80, preferably 30 to 70 wt .-% - based on the means - amount. The preparation of the means can in itself known way, d. H. for example by hot, cold, Hot-hot / cold or PIT emulsification take place. This is it a purely mechanical process, a chemical reaction fin det does not take place.

Schließlich können weitere an sich bekannte im UV-A-Bereich ab­ sorbierenden Substanzen mitverwendet werden, sofern sie im Ge­ samtsystem der erfindungsgemäß zu verwendenden Kombination aus UV-B und UV-A Filter stabil sind.Finally, others known per se in the UV-A range can be used Sorbing substances are also used, provided they are in the Ge complete system of the combination to be used according to the invention UV-B and UV-A filters are stable.

Gegenstand der vorliegenden Erfindung sind weiterhin kosmetische und pharmazeutische Zubereitungen, die 0,1 bis 10 Gew.-%, vor­ zugsweise 1 bis 7 Gew.-%, bezogen auf die gesamte Menge der kos­ metischen und pharmazeutischen Zubereitung, eine oder mehrere der Verbindungen der Formel I zusammen mit an sich für kosmetische und pharmazeutische Zubereitungen bekannten, im UV-B-Bereich ab­ sorbierenden Verbindungen als Lichtschutzmittel enthalten, wobei die Verbindungen der Formel I in der Regel in geringerer Menge als die UV-B-absorbierenden Verbindungen eingesetzt werden.The present invention also relates to cosmetic products and pharmaceutical preparations containing 0.1 to 10% by weight preferably 1 to 7 wt .-%, based on the total amount of kos metallic and pharmaceutical preparation, one or more of the Compounds of the formula I together with per se for cosmetic and pharmaceutical preparations known in the UV-B range Sorbent compounds contain as light stabilizers, wherein the compounds of the formula I usually in a smaller amount can be used as the UV-B absorbing compounds.

Der größte Teil der Lichtschutzmittel in den zum Schutz der menschlichen Epidermis dienenden kosmetischen und pharmazeuti­ schen Zubereitungen besteht aus Verbindungen, die UV-Licht im UV-B-Bereich absorbieren d. h. im Bereich von 280 bis 320 nm. Bei­ spielsweise beträgt der Anteil der erfindungsgemäß zu verwenden­ den UV-A-Absorber 10 bis 90 Gew.-%, bevorzugt 20 bis 50 Gew.-%, bezogen auf die Gesamtmenge von UV-B und UV-A absorbierenden Sub­ stanzen.Most of the sunscreens in the to protect the Cosmetic and pharmaceutical products used for human epidermis preparations consists of compounds that absorb UV light Absorb UV-B range d. H. in the range from 280 to 320 nm. At for example, the proportion is to be used according to the invention the UV-A absorber 10 to 90% by weight, preferably 20 to 50% by weight, based on the total amount of UV-B and UV-A absorbing sub punch.

Als UV-Filtersubstanzen, die in Kombination mit den erfindungsge­ mäß zu verwendenden Verbindungen der Formel I angewandt werden, kommen beliebige UV-A- und UV-B-Filtersubstanzen in Betracht.As UV filter substances, which in combination with the erfindungsge are used according to compounds of the formula I to be used, Any UV-A and UV-B filter substances can be used.

Beispielsweise sind zu nennen:
Examples include:

Schließlich sind auch mikronisierte Pigmente wie Titandioxid und Zinkoxid zu nennen.Finally, micronized pigments such as titanium dioxide and To mention zinc oxide.

Zum Schutz menschlicher Haare vor UV-Strahlen können die erfin­ dungsgemäßen Lichtschutzmittel der Formel I in Shampoos, Lotionen, Gelen, Haarsprays, Aerosol-Schaumcremes oder Emulsionen in Kon­ zentrationen von 0,1 bis 10 Gew.-%, bevorzugt 1 bis 7 Gew.-% eingearbeitet werden. Die jeweiligen Formulierungen können dabei u. a. zum Waschen, Färben sowie zum Frisieren der Haare verwendet werden.To protect human hair from UV rays, the inventions can proper light protection agent of the formula I in shampoos, lotions, Gels, hairsprays, aerosol foam creams or emulsions in con concentrations of 0.1 to 10% by weight, preferably 1 to 7% by weight be incorporated. The respective formulations can thereby i.a. used for washing, coloring and styling hair will.

Die erfindungsgemäß zu verwendenden Verbindungen zeichnen sich in der Regel durch ein besonders hohes Absorptionsvermögen im Be­ reich der UV-A-Strahlung mit scharfer Bandenstruktur aus. Weiter­ hin sind sie gut in kosmetischen Ölen löslich und lassen sich leicht in kosmetische Formulierungen einarbeiten. Die mit den Verbindungen I hergestellten Emulsionen zeichnen sich besonders durch ihre hohe Stabilität, die Verbindungen I selber durch ihre hohe Photostabilität aus, und die mit I hergestellten Zubereitun­ gen durch ihr angenehmes Hautgefühl aus. The compounds to be used according to the invention are distinguished usually due to a particularly high absorption capacity in the bed rich in UV-A radiation with a sharp band structure. Further they are well soluble in cosmetic oils and can be easily incorporated into cosmetic formulations. The ones with the Compounds I produced emulsions stand out particularly due to their high stability, the connections I themselves due to their high photostability, and the preparations made with I through their pleasant feeling on the skin.

Die UV-Filterwirkung der erfindungsgemäßen Verbindungen der For­ mel I kann auch zur Stabilisierung von Wirk- und Hilfsstoffen in kosmetischen und pharmazeutischen Formulierungen ausgenutzt wer­ den.The UV filter effect of the compounds according to the invention of For mel I can also be used to stabilize active ingredients and auxiliaries in cosmetic and pharmaceutical formulations who exploited the.

Gegenstand der Erfindung sind auch die Verbindungen der Formel I zur Verwendung als Medikament sowie pharmazeutische Mittel zur vorbeugenden Behandlung von Entzündungen und Allergien der Haut sowie zur Verhütung bestimmter Hautkrebsarten, welche eine wirk­ same Menge mindestens einer Verbindung der Formel I als Wirkstoff enthalten.The invention also relates to the compounds of the formula I for use as medicaments and pharmaceutical agents for preventive treatment of inflammation and allergies of the skin as well as for the prevention of certain types of skin cancers, which have an effective same amount of at least one compound of formula I as active ingredient contain.

Das erfindungsgemäße pharmazeutische Mittel kann oral oder to­ pisch verabreicht werden. Für die orale Verabreichung liegt das pharmazeutische Mittel in Form von u. a. Pastillen, Gelatinekap­ seln, Dragees, als Sirup, Lösung, Emulsion oder Suspension vor.The pharmaceutical agent according to the invention can be oral or to administered pisch. For oral administration that is pharmaceutical agents in the form of i.a. Lozenges, gelatine caps sugar, coated tablets, as a syrup, solution, emulsion or suspension.

Die topische Anwendung der pharmazeutischen Mittel erfolgt bei­ spielsweise als Salbe, Creme, Gel, Spray, Lösung oder Lotion.The topical application of the pharmaceutical agent takes place at for example as an ointment, cream, gel, spray, solution or lotion.

BeispieleExamples I. HerstellungI. Manufacture Beispiel 1example 1 Herstellvorschrift für die Verbindung der Nr. 1 der Tabelle 2Manufacturing instructions for the compound No. 1 in Table 2

0.1 mol β-Phenylzimtaldehyd und 0.1 mol Malonsäurediethylester werden in 100 ml Methanol gelöst, mit je 1 ml Piperidin und Eis­ essig versetzt und 5 h auf Rückfluß erhitzt. Anschließend wird mit Wasser verdünnt und mit Dichlormethan extrahiert. Die organische Phase wird mit Aktivkohle aufgerührt. Nach Abfiltrieren der orga­ nischen Phase wird über Natriumsulfat getrocknet und im Vakuum eingeengt. Der ölige Rückstand wird aus Methanol/Wasser umkri­ stallisiert. Man erhält 12 g (33% d. Th.) der Verbindung 1 der Tabelle 2 als farblose Kristalle. Reinheit: <99% (GC).0.1 mol of β-phenylcinnamaldehyde and 0.1 mol of diethyl malonate are dissolved in 100 ml of methanol, each with 1 ml of piperidine and ice added vinegar and heated to reflux for 5 h. Then with Diluted water and extracted with dichloromethane. The organic Phase is stirred up with activated charcoal. After filtering off the orga niche phase is dried over sodium sulfate and in vacuo constricted. The oily residue is recirculated from methanol / water installed. 12 g (33% of theory) of compound 1 are obtained Table 2 as colorless crystals. Purity: <99% (GC).

Die Herstellung der Verbindungen 2 bis 6 der Tabelle 2 erfolgt analog Beispiel 1.Compounds 2 to 6 in Table 2 are prepared analogous to example 1.

Beispiel 2Example 2 Herstellvorschrift für die Verbindung der Nr. 8 der Tabelle 2Manufacturing instructions for the connection of No. 8 in Table 2

0.1 mol Campher in 40 ml Xylol werden mit 0.1 mol KOH versetzt und auf Rückfluß erhitzt. Anschließend wird über 6 h langsam eine Lösung von 0.105 mol β-Phenylzimtaldehyd in Xylol zugetropft. 0.1 mol of camphor in 40 ml of xylene are mixed with 0.1 mol of KOH and heated to reflux. Then slowly one over 6 h A solution of 0.105 mol of β-phenylcinnamaldehyde in xylene was added dropwise.

Nach Abkühlen auf Raumtemperatur wird mit Wasser versetzt, die organische Phase zweimal mit Wasser gewaschen und anschließend über Natriumsulfat getrocknet. Nach Entfernen des Solvens wird der ölige Rückstand aus Methanol/Wasser kristallisiert. Man er­ hält 22 g (64%) farblose Kristalle der Verbindung 19 der Tabelle 1. Reinheit 99% (HPLC, Isomeren-Gemisch).After cooling to room temperature, water is added, which organic phase washed twice with water and then dried over sodium sulfate. After removing the solvent, the oily residue crystallized from methanol / water. Man he holds 22 g (64%) of colorless crystals of compound 19 of the table 1. Purity 99% (HPLC, isomer mixture).

Die Herstellung der Verbindung 7 der Tabelle 2 erfolgt durch Um­ setzung von β-Phenylzimtaldehyd mit Pinakolon analog Beispiel 2.Compound 7 of Table 2 is prepared by Um Settlement of β-phenylcinnamaldehyde with pinacolone as in Example 2.

Tabelle 2 Table 2

Beispiel 3Example 3 Standardisierte Methode zur Bestimmung der Photostabilität (Sun­ test)Standardized method for determining photostability (Sun test)

Eine 5 gew.-%ige alkoholische Lösung des zu prüfenden Licht­ schutzmittels wird mittels einer Eppendorfpipette (20 µ) auf die Auffräsung eines Glasplättchens aufgetragen. Durch die Anwesen­ heit des Alkohols verteilt sich die Lösung gleichmäßig auf der aufgerauhten Glasoberfläche. Die aufgetragene Menge entspricht der Menge an Lichtschutzmittel, die in Sonnencremes zur Erreichung eines mittleren Lichtschutzfaktors benötigt wird. Bei der Prüfung werden jeweils 4 Glasplättchen bestrahlt. Die Abdampfzeit und die Bestrahlung betragen je 30 Minuten. Die Glasplättchen werden wäh­ rend des Bestrahlens durch eine Wasserkühlung, die sich am Boden des Suntestgeräte befindet, leicht gekühlt. Die Temperatur inner­ halb des Suntest Gerätes beträgt während der Bestrahlung 40°C. Nachdem die Proben bestrahlt worden sind, werden sie mit Ethanol einen dunklen 50 ml Meßkolben gewaschen und mit dem Photometer vermessen. Die Blindproben werden ebenso auf Glasplättchen aufge­ tragen und 30 Minuten bei Raumtemperatur abgedampft. Wie die an­ deren Proben werden sie mit Ethanol abgewaschen und auf 100 ml verdünnt und vermessen.A 5% strength by weight alcoholic solution of the light to be tested protective agent is applied to the Milling of a glass plate applied. Through the estate The solution is evenly distributed over the alcohol roughened glass surface. The applied amount corresponds to Amount of sunscreen used in sunscreens to achieve a medium sun protection factor is required. During the exam 4 glass plates are irradiated in each case. The evaporation time and the Irradiation is 30 minutes each. The glass slides are weh rend of irradiation through a water cooling system, which is located on the ground of the sun test device is slightly cooled. The temperature inside half of the Suntest device is 40 ° C during irradiation. After the samples have been irradiated, they are washed with ethanol a dark 50 ml volumetric flask and washed with the photometer measured. The blank samples are also placed on glass slides wear and evaporated for 30 minutes at room temperature. Like that on their samples are washed off with ethanol and made up to 100 ml diluted and measured.

Vergleichsversuche bez. PhotostabilitätComparative tests with regard to photostability

Allgemeine Herstellvorschrift zur Herstellung von Emulsionen für kosmetische ZweckeGeneral manufacturing instructions for the manufacture of emulsions for cosmetic purposes

Alle öllöslichen Bestandteile werden in einem Rührkessel auf 85°C erwärmt. Wenn alle Bestandteile geschmolzen sind, bzw. als Flüssigphase vorliegen, wird die Wasserphase unter Homogenisieren eingearbeitet. Unter Rühren wird die Emulsion auf ca. 40°C abge­ kühlt, parfümiert, homogenisiert und dann unter ständigem Rühren auf 25°C abgekühlt.All oil-soluble components are in a stirred tank Heated to 85 ° C. When all components are melted or as If the liquid phase is present, the water phase is homogenized incorporated. The emulsion is removed to approx. 40 ° C. with stirring cools, perfumes, homogenizes and then with constant stirring cooled to 25 ° C.

ZubereitungenPreparations Beispiel 4Example 4 Zusammensetzung für die LippenpflegeComposition for lip care

Massengehalt
(Gew.-%)
Mass content
(Wt%)

ad 100 Eucerinum anhydricum
10,00 Glycerin
10,00 Titanium Dioxid
5,00 Verbindung Nr. 1 der Tabelle 2
8,00 Octyl Methoxycinnamat
5,00 Zink Oxid
4,00 Castoröl
4,00 Pentaerythrithil Stearat/caprat/Caprylat Adipat
3,00 Glyceryl Stearat SE
2,00 Bienenwachs
2,00 Microkristallines Wachs
2,00 Quaternium-18 Bentonit
1,50 PEG-45/Dodecyl Glycol Copolymer
ad 100 Eucerinum anhydricum
10.00 glycerin
10.00 titanium dioxide
5.00 Compound No. 1 of Table 2
8.00 octyl methoxycinnamate
5.00 zinc oxide
4.00 castor oil
4.00 Pentaerythrithil stearate / caprate / caprylate adipate
3.00 glyceryl stearate SE
2.00 beeswax
2.00 microcrystalline wax
2.00 Quaternium-18 bentonite
1.50 PEG-45 / dodecyl glycol copolymer

Beispiel 5Example 5 Zusammensetzung für die LippenpflegeComposition for lip care

Massengehalt
(Gew.-%)
Mass content
(Wt%)

ad 100 Eucerinum anhydricum
10,00 Glycerin
10,00 Titanium Dioxid
5,00 Verbindung Nr. 1 der Tabelle 2
8,00 Octyl Methoxycinnamat
5,00 Zink Oxid
4,00 Castoröl
4,00 Pentaerythrithil Stearat/caprat/Caprylat Adipat
3,00 Glyceryl Stearat SE
2,00 Bienenwachs
2,00 Microkristallines Wachs
2,00 Quaternium-18 Bentonit
1,50 PEG-45/Dodecyl Glycol Copolymer
ad 100 Eucerinum anhydricum
10.00 glycerin
10.00 titanium dioxide
5.00 Compound No. 1 of Table 2
8.00 octyl methoxycinnamate
5.00 zinc oxide
4.00 castor oil
4.00 Pentaerythrithil stearate / caprate / caprylate adipate
3.00 glyceryl stearate SE
2.00 beeswax
2.00 microcrystalline wax
2.00 Quaternium-18 bentonite
1.50 PEG-45 / dodecyl glycol copolymer

Beispiel 6Example 6 Zusammensetzung für Sunblocker mit MikropigmentenComposition for sunblock with micropigments

Massengehalt
(Gew.-%)
Mass content
(Wt%)

ad 100 Wasser
10,00 Octyl Methoxcinnamat
6,00 PEG-7-Hydrogenated Castor Öl
6,00 Titanium Dioxid
5,00 Verbindung Nr. 1 der Tabelle 2
5,00 Mineral Öl
5,00 Isoamyl p-Methoxycinnamat
5,00 Propylen Glycol
3,00 Jojoba Öl
3,00 4-Methylbenzyliden Campher
2,00 PEG-45/Dodecyl Glycol Copolymer
1,00 Dimethicon
0,50 PEG-40-Hydrogenated Castor 01
0,50 Tocopheryl Acetat
0,50 Phenoxyethanol
0,20 EDTA
ad 100 water
10.00 octyl methoxycinnamate
6.00 PEG-7 Hydrogenated Castor Oil
6.00 titanium dioxide
5.00 Compound No. 1 of Table 2
5.00 mineral oil
5.00 isoamyl p-methoxycinnamate
5.00 propylene glycol
3.00 jojoba oil
3.00 4-methylbenzylidene camphor
2.00 PEG-45 / dodecyl glycol copolymer
1.00 dimethicone
0.50 PEG-40-Hydrogenated Castor 01
0.50 tocopheryl acetate
0.50 phenoxyethanol
0.20 EDTA

Beispiel 7Example 7 Zusammensetzung für Sunblocker mit MikropigmentenComposition for sunblock with micropigments

Massengehalt
(Gew.-%)
Mass content
(Wt%)

ad 100 Wasser
10,00 Octyl Methoxcinnamat
6,00 PEG-7-Hydrogenated Castor Öl
6,00 Titanium Dioxid
5,00 Verbindung Nr. 1 der Tabelle 2
5,00 Mineral Öl
5,00 Isoamyl p-Methoxycinnamat
5,00 Propylen Glycol
3,00 Jojoba Öl
3,00 Jojoba Öl
2,00 4-Methylbenzyliden Campher
1,00 PEG-45/Dodecyl Glycol Copolymer
0,50 Dimethicon
0,50 PEG-40-Hydrogenated Castor Öl
0,50 Tocopheryl Acetat
0,20 Phenoxyethanol
0,20 EDTA
ad 100 water
10.00 octyl methoxycinnamate
6.00 PEG-7 Hydrogenated Castor Oil
6.00 titanium dioxide
5.00 Compound No. 1 of Table 2
5.00 mineral oil
5.00 isoamyl p-methoxycinnamate
5.00 propylene glycol
3.00 jojoba oil
3.00 jojoba oil
2.00 4-methylbenzylidene camphor
1.00 PEG-45 / Dodecyl Glycol Copolymer
0.50 dimethicone
0.50 PEG-40 Hydrogenated Castor Oil
0.50 tocopheryl acetate
0.20 phenoxyethanol
0.20 EDTA

Beispiel 8Example 8 Fettfreies GelFat-free gel

Massengehalt
(Gew.-%)
Mass content
(Wt%)

ad 100 Wasser
8,00 Octyl Methoxycinnamat
7,00 Titanium Dioxid
5,00 Verbindung Nr. 1 der Tabelle 2
5,00 Glycerin
5,00 PEG-25 PABA
1,00 PEG-25 PABA
0,40 4-Methylbenzyliden Campher
0,30 Acrylate C10-C30 Alkyl Acrylat Crosspolymer
0,25 Imidazolidinyl Urea
0,25 Hydroxyethyl Cellulose
0,20 Sodium Methylparaben
0,15 Disodium EDTA
0,15 Fragrance
0,15 Sodium Propylparaben
0,10 Sodium Hydroxid
ad 100 water
8.00 octyl methoxycinnamate
7.00 titanium dioxide
5.00 Compound No. 1 of Table 2
5.00 glycerin
5.00 PEG-25 PABA
1.00 PEG-25 PABA
0.40 4-methylbenzylidene camphor
0.30 Acrylate C10-C30 Alkyl Acrylate Crosspolymer
0.25 imidazolidinyl urea
0.25 hydroxyethyl cellulose
0.20 sodium methyl paraben
0.15 disodium EDTA
0.15 fragrance
0.15 sodium propyl paraben
0.10 sodium hydroxide

Beispiel 9Example 9 Fettfreies GelFat-free gel

Massengehalt
(Gew.-%)
Mass content
(Wt%)

ad 100 Wasser
8,00 Octyl Methoxycinnamat
7,00 Titanium Dioxid
5,00 Verbindung Nr. 1 der Tabelle 2
5,00 Glycerin
5,00 PEG-25 PABA
1,00 4-Methylbenzyliden Campher
0,40 Acrylate C10-C30 Alkyl Acrylat Crosspolymer
0,30 Imidazolidinyl Urea
0,25 Hydroxyethyl Cellulose
0,25 Sodium Methylparaben
0,20 Disodium EDTA
0,15 Fragrance
0,15 Sodium Propylparaben
0,10 Sodium Hydroxid
ad 100 water
8.00 octyl methoxycinnamate
7.00 titanium dioxide
5.00 Compound No. 1 of Table 2
5.00 glycerin
5.00 PEG-25 PABA
1.00 4-methylbenzylidene camphor
0.40 Acrylate C10-C30 alkyl acrylate cross polymer
0.30 imidazolidinyl urea
0.25 hydroxyethyl cellulose
0.25 sodium methyl paraben
0.20 disodium EDTA
0.15 fragrance
0.15 sodium propyl paraben
0.10 sodium hydroxide

Beispiel 10Example 10 Sonnencreme (LSF 20)Sunscreen (SPF 20)

Massengehalt
(Gew.-%)
Mass content
(Wt%)

ad 100 Wasser
8,00 Octyl Methoxycinnamat
8,00 Titanium Dioxid
6,00 PEG-7-Hydrogenated Castor Öl
5,00 Verbindung Nr. 1 der Tabelle 2
6,00 Mineral Öl
5,00 Zink Oxid
5,00 Isopropyl Palmitat
5,00 Imidazolidinyl Urea
3,00 Jojoba Öl
2,00 PEG-45/Dodecyl Glycol Copolymer
1,00 4-Methylbenzyliden Campher
0,60 Magnesium Stearat
0,50 Tocopheryl Acetat
0,25 Methylparaben
0,20 Disodium EDTA
0,15 Propylparaben
ad 100 water
8.00 octyl methoxycinnamate
8.00 titanium dioxide
6.00 PEG-7 Hydrogenated Castor Oil
5.00 Compound No. 1 of Table 2
6.00 mineral oil
5.00 zinc oxide
5.00 isopropyl palmitate
5.00 imidazolidinyl urea
3.00 jojoba oil
2.00 PEG-45 / dodecyl glycol copolymer
1.00 4-methylbenzylidene camphor
0.60 magnesium stearate
0.50 tocopheryl acetate
0.25 methyl paraben
0.20 disodium EDTA
0.15 propyl paraben

Beispiel 11Example 11 Sonnencreme (LSF 20)Sunscreen (SPF 20)

Massengehalt
(Gew.-%)
Mass content
(Wt%)

ad 100 Wasser
8,00 Octyl Methoxycinnamat
8,00 Titanium Dioxid
6,00 PEG-7-Hydrogenated Castor Öl
5,00 Verbindung Nr. 1 der Tabelle 2
6,00 Mineral Öl
5,00 Zink Oxid
5,00 Isopropyl Palmitat
5,00 Imidazolidinyl Urea
3,00 Jojoba Öl
2,00 PEG-45/Dodecyl Glycol Copolymer
1,00 4-Methylbenzyliden Campher
0,60 Magnesium Stearat
0,50 Tocopheryl Acetat
0,25 Methylparaben
0,20 Disodium EDTA
0,15 Propylparaben
ad 100 water
8.00 octyl methoxycinnamate
8.00 titanium dioxide
6.00 PEG-7 Hydrogenated Castor Oil
5.00 Compound No. 1 of Table 2
6.00 mineral oil
5.00 zinc oxide
5.00 isopropyl palmitate
5.00 imidazolidinyl urea
3.00 jojoba oil
2.00 PEG-45 / dodecyl glycol copolymer
1.00 4-methylbenzylidene camphor
0.60 magnesium stearate
0.50 tocopheryl acetate
0.25 methyl paraben
0.20 disodium EDTA
0.15 propyl paraben

Beispiel 12Example 12 Sonnencreme wasserfestWaterproof sunscreen

Massengehalt
(Gew.-%)
Mass content
(Wt%)

ad 100 Wasser
8,00 Octyl Methoxycinnamat
5,00 PEG-7-Hydrogenated Castor Öl
5,00 Propylene Glycol
4,00 Isopropyl Palmitat
4,00 Caprylic/Capric Triglycerid
5,00 Verbindung Nr. 1 der Tabelle 2
4,00 Glycerin
3,00 Jojoba Öl
2,00 4-Methylbenzyliden Campher
2,00 Titanium Dioxid
1,50 PEG-45/Dodecyl Glycol Copolymer
1,50 Dimethicon
0,70 Magnesium Sulfat
0,50 Magnesium Stearat
0,15 Fragrance
ad 100 water
8.00 octyl methoxycinnamate
5.00 PEG-7 Hydrogenated Castor Oil
5.00 Propylene Glycol
4.00 isopropyl palmitate
4.00 Caprylic / Capric Triglyceride
5.00 Compound No. 1 of Table 2
4.00 glycerin
3.00 jojoba oil
2.00 4-methylbenzylidene camphor
2.00 titanium dioxide
1.50 PEG-45 / dodecyl glycol copolymer
1.50 dimethicone
0.70 magnesium sulfate
0.50 magnesium stearate
0.15 fragrance

Beispiel 13Example 13 Sonnencreme wasserfestWaterproof sunscreen

Massengehalt
(Gew.-%)
Mass content
(Wt%)

ad 100 Wasser
8,00 Octyl Methoxycinnamat
5,00 PEG-7-Hydrogenated Castor Öl
5,00 Propylene Glycol
4,00 Isopropyl Palmitat
4,00 Caprylic/Capric Triglycerid
5,00 Verbindung Nr. 1 der Tabelle 2
4,00 Glycerin
3,00 Jojoba Öl
2,00 4-Methylbenzyliden Campher
2,00 Titanium Dioxid
1,50 PEG-45/Dodecyl Glycol Copolymer
1,50 Dimethicon
0,70 Magnesium Sulfat
0,50 Magnesium Stearat
0,15 Fragance
ad 100 water
8.00 octyl methoxycinnamate
5.00 PEG-7 Hydrogenated Castor Oil
5.00 Propylene Glycol
4.00 isopropyl palmitate
4.00 Caprylic / Capric Triglyceride
5.00 Compound No. 1 of Table 2
4.00 glycerin
3.00 jojoba oil
2.00 4-methylbenzylidene camphor
2.00 titanium dioxide
1.50 PEG-45 / dodecyl glycol copolymer
1.50 dimethicone
0.70 magnesium sulfate
0.50 magnesium stearate
0.15 Fragance

Beispiel 14Example 14 Sonnenmilch (LSF 6)Sun milk (SPF 6)

Massengehalt
(Gew.-%)
Mass content
(Wt%)

ad 100 Wasser
10,00 Mineral Öl
6,00 PEG-7-Hydrogenated Castor Öl
5,00 Isopropyl Palmitat
3,50 Octyl Methoxycinnamat
5,00 Verbindung Nr. 1 der Tabelle 2
3,00 Caprylic/Capric Triglycerid
3,00 Jojoba Öl
2,00 PEG-45/Dodecyl Glycol Copolymer
0,70 Magnesium Sulfat
0,60 Magnesium Stearat
0,50 Tocopheryl Acetat
0,30 Glycerin
0,25 Methylparaben
0,15 Propylparaben
0,05 Tocopherol
ad 100 water
10.00 mineral oil
6.00 PEG-7 Hydrogenated Castor Oil
5.00 isopropyl palmitate
3.50 octyl methoxycinnamate
5.00 Compound No. 1 of Table 2
3.00 Caprylic / Capric Triglyceride
3.00 jojoba oil
2.00 PEG-45 / dodecyl glycol copolymer
0.70 magnesium sulfate
0.60 magnesium stearate
0.50 tocopheryl acetate
0.30 glycerin
0.25 methyl paraben
0.15 propyl paraben
0.05 tocopherol

Beispiel 15Example 15 Sonnenmilch (LSF 6)Sun milk (SPF 6)

Massengehalt
(Gew.-%)
Mass content
(Wt%)

ad 100 Wasser
10,00 Mineral Öl
6,00 PEG-7-Hydrogenated Castor Öl
5,00 Isopropyl Palmitat
3,50 Octyl Methoxycinnamat
5,00 Verbindung Nr. 1 der Tabelle 2
3,00 Caprylic/Capric Triglycerid
3,00 Jojoba Öl
2,00 PEG-45/Dodecyl Glycol Copolymer
0,70 Magnesium Sulfat
0,60 Magnesium Stearat
0,50 Tocopheryl Acetat
0,30 Glycerin
0,25 Methylparaben
0,15 Propylparaben
0,05 Tocopherol
ad 100 water
10.00 mineral oil
6.00 PEG-7 Hydrogenated Castor Oil
5.00 isopropyl palmitate
3.50 octyl methoxycinnamate
5.00 Compound No. 1 of Table 2
3.00 Caprylic / Capric Triglyceride
3.00 jojoba oil
2.00 PEG-45 / dodecyl glycol copolymer
0.70 magnesium sulfate
0.60 magnesium stearate
0.50 tocopheryl acetate
0.30 glycerin
0.25 methyl paraben
0.15 propyl paraben
0.05 tocopherol

Beispiel 16Example 16 Sonnencreme wasserfestWaterproof sunscreen

Massengehalt
(Gew.-%)
Mass content
(Wt%)

ad 100 Wasser
8,00 Octyl Methoxycinnamat
5,00 PEG-7-Hydrogenated Castor Öl
5,00 Propylene Glycol
4,00 Isopropyl Palmitat
4,00 Caprylic/Capric Triglycerid
5,00 Verbindung Nr. 1 der Tabelle 2
4,00 Glycerin
3,00 Jojoba Öl
2,00 4-Methylbenzyliden Campher
2,00 Titanium Dioxid
1,50 PEG-45/Dodecyl Glycol Copolymer
1,50 Dimethicon
0,70 Magnesium Sulfat
0,50 Magnesium Stearat
0,15 Fragance
ad 100 water
8.00 octyl methoxycinnamate
5.00 PEG-7 Hydrogenated Castor Oil
5.00 Propylene Glycol
4.00 isopropyl palmitate
4.00 Caprylic / Capric Triglyceride
5.00 Compound No. 1 of Table 2
4.00 glycerin
3.00 jojoba oil
2.00 4-methylbenzylidene camphor
2.00 titanium dioxide
1.50 PEG-45 / dodecyl glycol copolymer
1.50 dimethicone
0.70 magnesium sulfate
0.50 magnesium stearate
0.15 Fragance

Beispiel 17Example 17 SonnenmilchSuntan lotion

Massengehalt
(Gew.-%)
Mass content
(Wt%)

ad 100 Wasser
10,00 Mineral Öl
6,00 PEG-7-Hydrogenated Castor Öl
5,00 Isopropyl Palmitat
3,50 Octyl Methoxycinnamat
5,00 Verbindung Nr. 1 der Tabelle 2
3,00 Caprylic/Capric Triglycerid
3,00 Jojoba Öl
2,00 PEG-45/Dodecyl Glycol Copolymer
0,70 Magnesium Sulfat
0,60 Magnesium Stearat
0,50 Tocopheryl Acetat
0,30 Glycerin
0,25 Methylparaben
0,15 Propylparaben
0,05 Tocopherol
ad 100 water
10.00 mineral oil
6.00 PEG-7 Hydrogenated Castor Oil
5.00 isopropyl palmitate
3.50 octyl methoxycinnamate
5.00 Compound No. 1 of Table 2
3.00 Caprylic / Capric Triglyceride
3.00 jojoba oil
2.00 PEG-45 / dodecyl glycol copolymer
0.70 magnesium sulfate
0.60 magnesium stearate
0.50 tocopheryl acetate
0.30 glycerin
0.25 methyl paraben
0.15 propyl paraben
0.05 tocopherol

Claims (8)

1. Verwendung von 4,4-Diarylbutadienen der Formel I,
in der das Diensystem in der Z,Z; Z,E; E,Z oder E,E Konfigu­ ration oder einer Mischung davon vorliegt und in der die Va­ riablen folgende Bedeutung haben:
R1 und R2 unabhängig voneinander Wasserstoff, C1-C20-Alkyl, C2-C10-Alkenyl, C3-C10-Cycloalkyl, C3-C10-Cycloalkenyl, C1-C12-Alkoxy, C1-C20-Alkoxycarbonyl, C1-C12-Alkylamino, C1-C12-Dialkylamino, Aryl, Heteroaryl, gegebenenfalls substituiert, wasserlöslich machende Substituenten, aus­ gewählt aus der Gruppe bestehend aus Carboxylat-, Sulfo­ nat- oder Ammoniumresten;
R3 Wasserstoff, COOR5, COR5, CONR5R6, CN, O=S(-R5)=O, O=S(-OR5)=O, R7O-P(-OR8)=O, C1-C20-Alkyl, C2-C10-Alkenyl, C3-C10-Cycloalkyl, C7-C10-Bi­ cycloalkyl, C3-C10-Cycloalkenyl, C7-C10-Bicycloalkenyl, Aryl, Heteroaryl, gegebenenfalls substituiert;
R4 COOR6, COR6, CONR5R6, CN, O=S(-R6)=O, O=S(-OR6)=O, R7O-P(-OR8)=O, C1-C20-Alkyl, C2-C10-Alkenyl, C3-C10-Cycloalkyl, C7-C10-Bi­ cycloalkyl, C3-C10-Cycloalkenyl, C7-C10-Bicycloalkenyl, Aryl, Heteroaryl, gegebenenfalls substituiert;
R5 bis R8 unabhängig voneinander Wasserstoff, C1-C20-Alkyl, C2-C10-Alkenyl, C3-C10-Cycloalkyl, C7-C10-Bicycloalkyl, C3-C10-Cycloalkenyl, C7-C10-Bicycloalkenyl, Aryl, Heteroa­ ryl, gegebenenfalls substituiert;
wobei die Variablen R3 bis R8 untereinander, jeweils zu­ sammen mit den Kohlenstoffatomen, an die sie gebunden sind, gemeinsam einen 5- oder 6-Ring bilden können, der gegebenenfalls weiter anelliert sein kann,
als photostabile UV-Filter in kosmetischen und pharmazeu­ tischen Zubereitungen zum Schutz der menschlichen Haut oder menschlicher Haare gegen Sonnenstrahlen, allein oder zusammen mit an sich für kosmetische und pharmazeutische Zubereitungen bekannten, im UV-Bereich absorbierenden Verbindungen.
1. Use of 4,4-diarylbutadienes of the formula I,
in which the diene system in the Z, Z; Z, E; E, Z or E, E configuration or a mixture thereof is available and in which the variables have the following meanings:
R 1 and R 2 independently of one another are hydrogen, C 1 -C 20 -alkyl, C 2 -C 10 -alkenyl, C 3 -C 10 -cycloalkyl, C 3 -C 10 -cycloalkenyl, C 1 -C 12 -alkoxy, C 1 -C 20 alkoxycarbonyl, C 1 -C 12 alkylamino, C 1 -C 12 dialkylamino, aryl, heteroaryl, optionally substituted, water-solubilizing substituents selected from the group consisting of carboxylate, sulfonate or ammonium radicals;
R 3 hydrogen, COOR 5 , COR 5 , CONR 5 R 6 , CN, O = S (-R 5 ) = O, O = S (-OR 5 ) = O, R 7 OP (-OR 8 ) = O, C 1 -C 20 alkyl, C 2 -C 10 alkenyl, C 3 -C 10 cycloalkyl, C 7 -C 10 bicycloalkyl, C 3 -C 10 cycloalkenyl, C 7 -C 10 bicycloalkenyl, aryl , Heteroaryl, optionally substituted;
R 4 COOR 6 , COR 6 , CONR 5 R 6 , CN, O = S (-R 6 ) = O, O = S (-OR 6 ) = O, R 7 OP (-OR 8 ) = O, C 1 -C 20 -alkyl, C 2 -C 10 -alkenyl, C 3 -C 10 -cycloalkyl, C 7 -C 10 -bi cycloalkyl, C 3 -C 10 -cycloalkenyl, C 7 -C 10 -bicycloalkenyl, aryl, heteroaryl , optionally substituted;
R 5 to R 8 independently of one another are hydrogen, C 1 -C 20 alkyl, C 2 -C 10 alkenyl, C 3 -C 10 cycloalkyl, C 7 -C 10 bicycloalkyl, C 3 -C 10 cycloalkenyl, C 7 -C 10 -Bicycloalkenyl, aryl, Heteroa ryl, optionally substituted;
where the variables R 3 to R 8 with one another, in each case together with the carbon atoms to which they are bound, can together form a 5- or 6-ring, which can optionally be further fused,
as photostable UV filters in cosmetic and pharmaceutical preparations for protecting the human skin or human hair against sun rays, alone or together with compounds that are known per se for cosmetic and pharmaceutical preparations and absorb in the UV range.
2. Verwendung von Verbindungen der Formel I gemäß Anspruch 1 als photostabile UV-A-Filter.2. Use of compounds of formula I according to claim 1 as photostable UV-A filters. 3. Verwendung von Verbindungen der Formel I gemäß den Ansprü­ chen 1 und 2 als UV-Stabilisator in kosmetischen und pharma­ zeutischen Formulierungen.3. Use of compounds of the formula I according to claims chen 1 and 2 as UV stabilizers in cosmetic and pharmaceuticals zeutic formulations. 4. Verwendung von Verbindungen der Formel I gemäß den Ansprü­ chen 1 bis 3, wobei die Substituenten folgende Bedeutung ha­ ben:
R1 und R2 unabhängig voneinander Wasserstoff, C1-C12-Alkyl, C1-C8-Alkoxy, C1-C12-Alkylamino, C1-C12-Dialkylamino, wasserlöslich machende Substituenten, ausgewählt aus der Gruppe bestehend aus Carboxylat-, Sulfonat- oder Ammoni­ umresten;
R3 Wasserstoff, COOR5, COR5, CONR5R6, CN, C1-C12-Alkyl, C3-C6-Cycloalkyl, C7-C10-Bicycloalkyl, Phenyl, Naphthyl, Thienyl, gegebenenfalls substituiert;
R4 COOR6, COR6, CONR5R6, CN, C1-C12-Alkyl, C3-C6-Cycloalkyl, C7-C10-Bicycloalkyl, Phenyl, Naphthyl, Thienyl, gegebe­ nenfalls substituiert;
R5 und R6 unabhängig voneinander Wasserstoff, C1-C12-Alkyl, C3-C6-Cycloalkyl, C7-C10-Bicycloalkyl, Phenyl, Naphthyl, gegebenenfalls substituiert.
4. Use of compounds of the formula I according to claims 1 to 3, where the substituents have the following meanings:
R 1 and R 2 independently of one another are hydrogen, C 1 -C 12 -alkyl, C 1 -C 8 -alkoxy, C 1 -C 12 -alkylamino, C 1 -C 12 -dialkylamino, water-solubilizing substituents selected from the group consisting of residues from carboxylate, sulfonate or ammonium;
R 3 is hydrogen, COOR 5 , COR 5 , CONR 5 R 6 , CN, C 1 -C 12 alkyl, C 3 -C 6 cycloalkyl, C 7 -C 10 bicycloalkyl, phenyl, naphthyl, thienyl, optionally substituted;
R 4 COOR 6 , COR 6 , CONR 5 R 6 , CN, C 1 -C 12 alkyl, C 3 -C 6 cycloalkyl, C 7 -C 10 bicycloalkyl, phenyl, naphthyl, thienyl, optionally substituted;
R 5 and R 6 independently of one another are hydrogen, C 1 -C 12 alkyl, C 3 -C 6 cycloalkyl, C 7 -C 10 bicycloalkyl, phenyl, naphthyl, optionally substituted.
5. Lichtschutzmittel enthaltende kosmetische und pharmazeutische Zubereitungen zum Schutz der menschlichen Epidermis oder menschlichen Haare gegen UV-Licht im Bereich von 280 bis 400 nm, dadurch gekennzeichnet, daß sie in einem kosmetisch und pharmazeutisch geeigneten Träger, allein oder zusammen mit an sich für kosmetische und pharmazeutische Zubereitungen bekannten im UV-Bereich absorbierenden Verbindungen, als pho­ tostabile UV-Filter wirksame Mengen von Verbindungen der For­ mel I
enthalten, in der die Variablen die Bedeutung gemäß Anspruch 1 haben.
5. Cosmetic and pharmaceutical preparations containing light stabilizers for protecting the human epidermis or human hair against UV light in the range from 280 to 400 nm, characterized in that they are in a cosmetically and pharmaceutically suitable carrier, alone or together with per se for cosmetic and pharmaceutical preparations known in the UV range absorbing compounds, effective as photo-stable UV filters amounts of compounds of the formula I
contain, in which the variables have the meaning according to claim 1.
6. Lichtschutzmittel enthaltende kosmetische und pharmazeutische Zubereitungen gemäß Anspruch 5, enthaltend als UV-A-Filter Verbindungen der Formel I, in der die Variablen die Bedeutung gemäß Anspruch 4 haben.6. Cosmetic and pharmaceutical products containing light stabilizers Preparations according to claim 5, containing as UV-A filter Compounds of the formula I in which the variables have the meaning according to claim 4 have. 7. Verbindungen der Formel I zur Verwendung als Arzneimittel.7. Compounds of the formula I for use as medicaments. 8. Pharmazeutische Zubereitung, dadurch gekennzeichnet, daß sie eine wirksame Menge mindestens einer der Verbindung der For­ mel I nach Anspruch 1 enthält.8. Pharmaceutical preparation, characterized in that it an effective amount of at least one of the compounds of the For mel I according to claim 1 contains.
DE19746654A 1997-08-13 1997-10-22 Use of 4,4-di:aryl-butadiene derivatives as photostable UV filter compounds Withdrawn DE19746654A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE19746654A DE19746654A1 (en) 1997-08-13 1997-10-22 Use of 4,4-di:aryl-butadiene derivatives as photostable UV filter compounds
ES98114967T ES2231925T3 (en) 1997-08-13 1998-08-10 COSMETIC AND PHARMACEUTICAL PREPARATIONS CONTAINING UV PHOTOSTABLE FILTERS.
DE59812214T DE59812214D1 (en) 1997-08-13 1998-08-10 Cosmetic and pharmaceutical preparations containing photostable UV filters
EP98114967A EP0916335B1 (en) 1997-08-13 1998-08-10 Cosmetic and parmaceutical compositions containing a photostable UV filter
US09/133,173 US6238649B1 (en) 1997-08-13 1998-08-13 Cosmetic and pharmaceutical preparations containing photostable UV filters
AU79977/98A AU748711B2 (en) 1997-08-13 1998-08-13 Cosmetic and pharmaceutical preparations containing photostable UV filters
JP22888398A JP3964989B2 (en) 1997-08-13 1998-08-13 Use of 4,4-diarylbutadiene as a light-resistant UV filter, cosmetic or pharmaceutical preparations containing sunscreens, 4,4-diarylbutadienes and pharmaceutical preparations
CNB981205585A CN1271988C (en) 1997-08-13 1998-08-13 Cosmetics and medicinal preparation containing lightfast ultraviolet filter agent
US09/765,624 US6545174B2 (en) 1997-08-13 2001-01-22 Cosmetic and pharmaceutical preparations containing photostable UV filters

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19735093 1997-08-13
DE19746654A DE19746654A1 (en) 1997-08-13 1997-10-22 Use of 4,4-di:aryl-butadiene derivatives as photostable UV filter compounds

Publications (1)

Publication Number Publication Date
DE19746654A1 true DE19746654A1 (en) 1999-02-18

Family

ID=7838862

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19746654A Withdrawn DE19746654A1 (en) 1997-08-13 1997-10-22 Use of 4,4-di:aryl-butadiene derivatives as photostable UV filter compounds

Country Status (1)

Country Link
DE (1) DE19746654A1 (en)

Cited By (169)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818130A1 (en) * 2000-12-18 2002-06-21 Oreal ANTISOLAR COSMETIC COMPOSITIONS BASED ON A SYNERGETIC MIXTURE OF FILTERS AND USES
FR2818128A1 (en) * 2000-12-18 2002-06-21 Oreal ANTISOLAR COSMETIC COMPOSITIONS BASED ON A SYNERGETIC MIXTURE OF FILTERS AND USES
FR2818144A1 (en) * 2000-12-18 2002-06-21 Oreal Photoprotective cosmetic or dermatological composition comprises a bis-resorcinyl triazine filter and a 4,4-diarylbutadiene filter
FR2818145A1 (en) * 2000-12-18 2002-06-21 Oreal ANTISOLAR COSMETIC COMPOSITIONS BASED ON A SYNERGETIC MIXTURE OF FILTERS AND USES
FR2818129A1 (en) * 2000-12-18 2002-06-21 Oreal PHOTOSTABLE FILTERING COMPOSITION CONTAINING UV FILTER DERIVED FROM DIBENZOYLMETHANE, P-METHYL-BENZYLIDENE CAMPHOR AND 4,4-DIARYLBUTADIENE COMPOUND
FR2818142A1 (en) * 2000-12-18 2002-06-21 Oreal Photoprotective cosmetic or dermatological composition useful as e.g. a sunscreen, comprises a filter with at least one or two benzazole groups and a 4,4-diarylbutadiene filter
FR2818126A1 (en) * 2000-12-18 2002-06-21 Oreal PHOTOSTABLE FILTERING COMPOSITION CONTAINING A 1,3,5-TRIZAZINE DERIVATIVE, A DIBENZOYLMETHANE DERIVATIVE AND A 4,4-DIARYLBUTADIENE COMPOUND
FR2818127A1 (en) * 2000-12-18 2002-06-21 Oreal PHOTOSTABLE FILTERING COMPOSITION CONTAINING A DIBENZOYLMETHANE-DERIVED TYPE FILTER AND A 4,4-DIARYLBUTADIENE COMPOUND
FR2818143A1 (en) * 2000-12-18 2002-06-21 Oreal Photoprotective cosmetic or dermatological composition useful for e.g. a sunscreen, comprises a benzotriazole-functional silicon-containing filter and a 4,4-diarylbutadiene filter
EP1618870A1 (en) 2004-07-02 2006-01-25 L'oreal Process for photostabilising a dibenzoylmethane derivative with an arylalkyl benzoate derivative and sunscreening cosmetic compositions
EP1671680A1 (en) 2004-12-20 2006-06-21 L'oreal Self-tanning composition having two components, multicompartment device and process for colouring the skin
EP1674069A1 (en) 2004-12-17 2006-06-28 L'oreal Cosmetic method for performing skin care and kit therefor
EP1688127A1 (en) 2005-01-18 2006-08-09 L'oreal Hair treatment composition containing an aromatic alcohol, an aromatic carboxylic acid a protecting agent
EP1705187A1 (en) 2005-03-18 2006-09-27 L'oreal Cosmetic compositions comprising KAP-polypeptides for care, strengthening, and/or repair of substrates consisting of keratin
US7378103B2 (en) 2004-03-22 2008-05-27 L'oreal Cosmetic composition comprising a polyglycerolated silicone elastomer
EP1997473A2 (en) 2007-04-30 2008-12-03 L'Oreal Use of a multi-carbosite, multi-group coupling agent for protecting the colour of artificially dyed keratin fibres with respect to washing; dyeing processes
EP2011481A2 (en) 2007-07-06 2009-01-07 L'Oreal Sun-protection composition containing the association of a semi-crystalline polymer and hollow latex particles
EP2014277A1 (en) 2007-07-12 2009-01-14 L'Oreal Aqueous liquid photoprotective composition based on a polyamide polymer with tertiary amide termination
EP2016932A2 (en) 2007-07-09 2009-01-21 L'Oréal Use of dehydroascorbic acid or its polymer derivatives for skin colouring; care and/or make-up methods
EP2100585A1 (en) 2008-03-11 2009-09-16 L'Oréal Cosmetic composition comprising an ascorbic acid or salicylic acid compound
EP2119429A1 (en) 2008-05-14 2009-11-18 L'Oréal Cosmetic composition containing a dibenzoylmethane derivative and a pyrrolidinone derivative; method for photostabilising the dibenzoylmethane derivative
EP2168567A1 (en) 2008-09-24 2010-03-31 L'Oréal Uses of dithiolane compounds for the photoprotection of the skin, dithiolane compounds and compositions containing same
EP2174644A1 (en) 2008-10-08 2010-04-14 L'oreal Cosmetic composition comprising a dibenzoylmethane derivative and a dithiolane; Photostabilization of a dibenzoylmethane derivative
EP2191869A1 (en) 2008-12-01 2010-06-02 L'oreal Method for artificially colouring the skin using a mixture of carotenoid and of lipophilic green dye; novel mixture of lipophilic dyes; composition
EP2193784A1 (en) 2008-12-08 2010-06-09 L'oreal Cosmetic compositions containing an ester derivative of 2-pyrrolidinone 4-carboxy and a lipophilic triazine filter, with use of said derivative as a solvent of a lipophilic triazine filter
EP2193782A1 (en) 2008-12-08 2010-06-09 L'Oreal Cosmetic composition comprising a dibenzoylmethane derivative and a 2-pyrrolidinone-4-carboxy ester compound; method for the photostabilization of the dibenzoylmethane derivative
EP2196189A1 (en) 2001-12-07 2010-06-16 L'oreal Cosmetic sunscreen compositions based on synergistic filter mixture and their use
EP2198837A1 (en) 2008-12-22 2010-06-23 L'oreal Cosmetic composition containing four surfactants, a cationic polymer and a zinc salt
EP2204165A1 (en) 2008-12-30 2010-07-07 L'oreal Combination of monosaccharides with solar filters and cosmetic use thereof
WO2011004133A2 (en) 2009-07-10 2011-01-13 L'oreal Composite material comprising uv filters and plasmonic particles, and use as sun screen
WO2011023886A2 (en) 2009-08-28 2011-03-03 L'oreal Composition containing at least one lipophilic 2-hydroxybenzophenone filter and a silicon s-triazine substituted by at least two alkylaminobenzoate groups
EP2301518A2 (en) 2009-08-28 2011-03-30 L'Oréal Cosmetic composition including a hydroxylated diphenyl-methane derivative
WO2011042358A1 (en) 2009-10-08 2011-04-14 L'oreal Photoprotective composition based on a 2-alkoxy-4-alkyl ketone phenol compound; use of said compound for increasing the sun protection factor
WO2011045741A2 (en) 2009-10-12 2011-04-21 L'oreal Photonic particles; compositions containing them; methods of photoprotecting various materials
WO2011045740A2 (en) 2009-10-12 2011-04-21 L'oreal Methods of photoprotecting a material against solar uv radiation using photonic particles; compositions
WO2011045746A2 (en) 2009-10-12 2011-04-21 L ' Oreal A composition comprising a dispersion of photonic particles; methods of treating various materials
WO2011073279A2 (en) 2009-12-18 2011-06-23 L'oreal Cosmetic treatment method involving a compound capable of condensing in situ
WO2011074141A1 (en) 2009-12-18 2011-06-23 L'oreal Process for treating keratin fibers
WO2011080043A1 (en) 2010-01-04 2011-07-07 L'oreal Ureidopyrimidones; cosmetic use as uv-screening agents; antisun compositions containing them
WO2011113718A1 (en) 2010-03-15 2011-09-22 L'oreal Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent
WO2011113719A2 (en) 2010-03-15 2011-09-22 L'oreal Composition comprising a dibenzoylmethane screening agent and a merocyanine dicyano or cyanoacetate derivative; method for the photostabilization of the dibenzoylmethane screening agent
WO2011151203A2 (en) 2010-06-03 2011-12-08 L'oreal Cosmetic treatment process using a coating based on a copolymer containing polyamide blocks and polyether blocks
WO2011157746A1 (en) 2010-06-16 2011-12-22 L'oreal Cosmetic antioxidant aromatic c-glycosides
WO2012010554A1 (en) 2010-07-20 2012-01-26 L'oreal Use of compounds resulting from a sugar polyol or from a dehydrogenated sugar polyol derivative as a uv-screening agent; antisun compositions containing same; and novel compounds
WO2012059348A1 (en) 2010-11-05 2012-05-10 L'oreal Fluid aqueous antisun composition based on a superabsorbent polymer and a crosslinked copolymer of methacrylic acid and of a c1-c4 alkyl acrylate
US8241615B2 (en) 2009-10-19 2012-08-14 L'oreal S.A. Water-resistant sunscreen composition
WO2012119860A1 (en) 2011-03-09 2012-09-13 L'oreal Cosmetic composition containing a dibenzoylmethane derivative and a monoester-monoamide compound of methylsuccinic acid; process for photostabilizing a dibenzoylmethane derivative
WO2012160289A2 (en) 2011-05-20 2012-11-29 L'oreal Cosmetic composition comprising a superabsorbent polymer and a carbohydrate chosen from monosaccharides, oligosaccharides and homopolysaccharides
WO2012172057A2 (en) 2011-06-16 2012-12-20 L'oreal Use of a compound comprising at least one nucleophilic function for capturing carbonyl compounds resulting from the reaction between one or more compounds constituting sebum and ozone
WO2013004777A1 (en) 2011-07-07 2013-01-10 L'oreal Photoprotective composition
WO2013010590A1 (en) 2011-07-21 2013-01-24 L'oreal Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities
WO2013068237A1 (en) 2011-11-07 2013-05-16 L'oreal Composition with a continuous oil phase containing at least one lipophilic organic uv-screening agent and hydrophobic silica aerogel particles
US8454942B1 (en) 2011-11-29 2013-06-04 L'oreal Cosmetic oil mousse composition
WO2013080140A2 (en) 2011-12-02 2013-06-06 L'oreal Sunscreen compositions containing a novel preservative system
WO2013117449A1 (en) 2012-02-06 2013-08-15 L'oreal Non-pulverulent antisun composition comprising a polar oil phase and hydrophobic silica aerogel particles
WO2014006589A2 (en) 2012-07-04 2014-01-09 L'oreal Photoprotective cosmetic composition
WO2014009097A1 (en) 2012-07-13 2014-01-16 L'oreal Cosmetic composition containing screening composite particles
WO2014060405A2 (en) 2012-10-15 2014-04-24 L'oreal Aqueous wax dispersions and hair styling compositions containing them
WO2014105877A1 (en) 2012-12-27 2014-07-03 L'oreal Low viscosity meta-stable photoprotection composition
WO2014111569A2 (en) 2013-01-21 2014-07-24 L'oreal Anhydrous cosmetic or dermatological composition comprising a merocyanine and an oily phase
WO2014111567A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and a uva-screening agent of the amino-substituted 2-hydroxybenzophenone type and/or a hydrophilic organic uva-screening agent
WO2014111562A1 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological emulsion comprising a merocyanine and an emulsifying system containing an alkali metal salt of a phosphoric acid ester of a fatty alcohol
WO2014111563A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and a lipophilic benzotriazole uv-screening agent and/or a bis-resorcinyl triazine compound
WO2014111570A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one specific amide compound
WO2014111568A1 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological water-in-oil emulsion comprising a merocyanine and at least one emulsifying polymer of the polyoxyalkylenated glycol fatty acid ester type
WO2014111571A1 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological emulsion comprising a merocyanine and an emulsifying system containing an amphiphilic polymer comprising at least one 2-acrylamidomethylpropanesulfonic acid unit
WO2014111566A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an insoluble organic uv-screening agent and/or an insoluble inorganic uv- screening agent
WO2014111564A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine, an oily phase and a c1-c4 monoalkanol
WO2014111565A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological emulsion comprising a merocyanine and an emulsifying system containing a gemini surfactant
US8790623B2 (en) 2005-01-18 2014-07-29 Il'Oreal Composition for treating keratin fibers, comprising at least one aromatic alcohol, at least one aromatic carboxylic acid, and at least one protecting agent
WO2014167225A1 (en) 2013-04-08 2014-10-16 Universite De Rennes 1 Photoprotective compounds, compositions including same and uses thereof
WO2014192780A1 (en) 2013-05-30 2014-12-04 L'oreal Cosmetic composition
WO2014191324A1 (en) 2013-05-29 2014-12-04 L'oreal Composite particles based on mineral uv-screening agent and perlite; cosmetic or dermatological compositions containing the same
WO2015089035A1 (en) 2013-12-09 2015-06-18 Momentive Performance Materials Inc. Emulsion compositions and applications therefor
WO2015140472A1 (en) 2014-03-19 2015-09-24 L'oreal Cosmetic composition comprising beneficial agents for keratin materials, and a mixture of sulfonate-containing derivatives of olefins, and cosmetic treatment method
WO2015186078A1 (en) 2014-06-04 2015-12-10 L'oreal High uv protection alcohol-free anydrous clear system
WO2016030839A1 (en) 2014-08-28 2016-03-03 L'oreal Gel composition and gel comprising a uv filter
WO2016050778A1 (en) 2014-09-30 2016-04-07 L'oreal High uv protection alcohol-free emulsion system, that is clear on application
US9308155B2 (en) 2005-07-13 2016-04-12 L'oreal Photoprotective composition and screening agents for said composition
WO2016083404A1 (en) 2014-11-24 2016-06-02 L'oreal Cosmetic composition comprising a synthetic phyllosilicate and a polyol and/or a uv filter
US9381383B2 (en) 2009-10-22 2016-07-05 L'oreal Photoprotective compositions and films, and a preparation method
WO2016119028A1 (en) 2015-01-29 2016-08-04 L'oreal Transparent sunscreen composition
US9408785B2 (en) 2012-10-15 2016-08-09 L'oreal Hair styling compositions containing aqueous wax dispersions
WO2016198581A1 (en) 2015-06-11 2016-12-15 L'oreal Composition comprising a uv-screening agent, an anionic crosslinked hydrophilic polymer, a surfactant having an hlb less than or equal to 5 and a silicone copolymer
WO2016203062A1 (en) 2015-09-25 2016-12-22 Rhodia Operations Cosmetic photoprotection composition
WO2016204947A1 (en) 2015-06-19 2016-12-22 L'oreal Sunscreen composition containing high levels of liposoluble uv filters
WO2016204946A1 (en) 2015-06-19 2016-12-22 L'oreal Water-in-oil sunscreen composition having organic sunscreen actives
WO2017000050A1 (en) 2015-06-29 2017-01-05 L'oreal Oil controlling sunscreen composition
US9579276B2 (en) 2013-12-12 2017-02-28 L'oreal Clear sunscreen composition for application onto wet or dry skin
WO2017129674A1 (en) 2016-01-26 2017-08-03 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one polyalkylene glycol.
WO2017129673A1 (en) 2016-01-26 2017-08-03 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one di- or tricarboxylic acid ester
WO2017129670A1 (en) 2016-01-26 2017-08-03 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one n-substituted amide
WO2017129669A1 (en) 2016-01-26 2017-08-03 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one isosorbide ether
WO2017189301A1 (en) 2016-04-29 2017-11-02 L'oreal Uv-a/uv-b sunscreen composition
WO2018115493A1 (en) 2016-12-23 2018-06-28 L'oreal Composition comprising baicalin
WO2018115360A1 (en) 2016-12-21 2018-06-28 L'oreal Composition comprising baicalin, a fatty acid ester and an alkylpolyglycoside
WO2018159139A1 (en) 2017-02-28 2018-09-07 L'oreal Composition comprising resorcinol or derivative thereof
WO2018206764A1 (en) 2017-05-12 2018-11-15 L'oreal Photostable composition made from perlite/titanium/silica composite particles
WO2019002495A1 (en) 2017-06-29 2019-01-03 L'oreal Photoprotective compositions comprising a dibenzoylmethane derivative, a merocyanine compound and a compound capable of accepting the triplet excited level energy of the dibenzoylmethane compound
US10292922B2 (en) 2015-12-31 2019-05-21 L'oreal Silicone-wax dispersion compositions for removing cosmetic films
WO2019096956A1 (en) 2017-11-15 2019-05-23 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an acrylic polymer
WO2019096953A1 (en) 2017-11-15 2019-05-23 L'oreal Cosmetic emulsion containing a gemini surfactant and a lipophilic polymer
WO2019102114A1 (en) 2017-11-24 2019-05-31 Rhodia Operations Cerium oxide/silica particles
WO2019119077A1 (en) 2017-12-19 2019-06-27 L'oreal Sun care composition
WO2019121636A1 (en) 2017-12-19 2019-06-27 L'oreal Composition comprising baicalin and an antioxidant compound
WO2019119078A1 (en) 2017-12-19 2019-06-27 L'oreal Sun care composition
US10413496B2 (en) 2012-10-15 2019-09-17 L'oreal Aqueous wax dispersions
WO2019209483A1 (en) 2018-04-23 2019-10-31 L'oreal Memory-shape sunscreen composition
WO2019210376A1 (en) 2018-04-30 2019-11-07 L'oreal Sunscreen compositions
WO2020000068A1 (en) 2018-06-28 2020-01-02 L'oreal Surfactant system and sunscreen composition comprising it
WO2020002537A1 (en) 2018-06-28 2020-01-02 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one alkyl or alkylene carbonate
WO2020024023A1 (en) 2018-07-31 2020-02-06 L'oreal Sunscreen composition, use of the sunscreen composition and process of manufacturing the sunscreen composition
WO2020024022A1 (en) 2018-07-31 2020-02-06 L'oreal Sun care composition for whitening the skin, use of the sun care composition, and process of manufacture of the sun care composition
US10561596B2 (en) 2014-04-11 2020-02-18 L'oreal Compositions and dispersions containing particles comprising a polymer
US10626294B2 (en) 2012-10-15 2020-04-21 L'oreal Aqueous wax dispersions containing volatile solvents
WO2020127760A1 (en) 2018-12-20 2020-06-25 L'oreal Cosmetic treatment process comprising the generation of a foam from two anhydrous compositions
WO2020127100A1 (en) 2018-12-21 2020-06-25 L'oreal Fluid photoprotective composition
FR3090329A1 (en) 2018-12-21 2020-06-26 L'oreal Composition comprising a UV filter, an anionic crosslinked hydrophilic polymer, a surfactant having an HLB less than or equal to 5 and a non-volatile alkane
WO2020163928A1 (en) 2019-02-13 2020-08-20 L'oreal Sunscreen composition, use of the sunscreen composition and process of manufacturing the sunscreen composition
WO2020172726A1 (en) 2019-02-28 2020-09-03 L'oreal Anti-acne sunscreen composition, process for manufacturing an anti-acne sunscreen composition and use of an anti-acne sunscreen composition
WO2020172725A1 (en) 2019-02-28 2020-09-03 L'oreal Sunscreen composition, use of a sunscreen composition, use of the liquid carnauba wax and process of manufacturing a sunscreen composition
US10835479B2 (en) 2015-12-31 2020-11-17 L'oreal Systems and methods for improving the appearance of the skin
WO2021016684A1 (en) 2019-07-31 2021-02-04 L'oreal Cosmetic composition, process for manufacturing the cosmetic composition and its use
FR3103704A1 (en) 2019-11-29 2021-06-04 L'oreal Composition comprising a UV filter, an ethylenic polymer with a phosphonic acid group and a hydrocarbon oil
FR3103705A1 (en) 2019-11-29 2021-06-04 L'oreal A composition comprising a UV filter, a block polymer containing a phosphonic acid group and a hydrocarbon oil
WO2021123337A1 (en) 2019-12-20 2021-06-24 L'oreal Retinol-based composition
WO2021123233A1 (en) 2019-12-20 2021-06-24 L'oreal Retinol-based composition
US11191710B2 (en) 2015-12-23 2021-12-07 L'oreal Photoprotective cosmetic composition and process for obtaining the same
FR3111075A1 (en) 2020-06-08 2021-12-10 L'oreal Retinol-based composition
FR3111074A1 (en) 2020-06-08 2021-12-10 L'oreal Retinol-based composition
FR3111809A1 (en) 2020-06-30 2021-12-31 L'oreal Photoprotective cosmetic composition, use of a photoprotective cosmetic composition and process for the manufacture of a photoprotective cosmetic composition
WO2022084458A1 (en) 2020-10-23 2022-04-28 L'oreal Photoprotective composition
FR3115991A1 (en) 2020-11-06 2022-05-13 L'oreal Solid anhydrous composition comprising a lipophilic organic UV filter, a hydrocarbon oil, and at least 10% of a high melting point wax
WO2022129039A1 (en) 2020-12-18 2022-06-23 L'oreal Cosmetic composition comprising a merocyanine, a triazine uv-screening agent, and a polysaccharide modified with hydrophobic chains
WO2022129059A1 (en) 2020-12-18 2022-06-23 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one citric acid ester
FR3117853A1 (en) 2020-12-23 2022-06-24 L'oreal Cosmetic composition comprising polymeric particles based on acetoacetate functions
FR3117852A1 (en) 2020-12-23 2022-06-24 L'oréal Cosmetic composition comprising a copolymer based on acetoacetate functions
FR3117794A1 (en) 2020-12-23 2022-06-24 L'oreal Aqueous dispersion of a specific copolymer and its cosmetic applications
FR3117856A1 (en) 2020-12-23 2022-06-24 L'oréal Cosmetic composition comprising a block copolymer based on acetoacetate functions
WO2022136110A1 (en) 2020-12-23 2022-06-30 L'oreal Cosmetic composition comprising polymer particles based on acetoacetate functions
WO2022136104A1 (en) 2020-12-23 2022-06-30 L'oreal Cosmetic composition comprising a copolymer based on acetoacetate functions
WO2022136114A1 (en) 2020-12-23 2022-06-30 L'oreal Aqueous dispersion of a specific copolymer, and cosmetic uses thereof
US11382855B2 (en) 2014-12-18 2022-07-12 L'oreal Compositions and methods for improving the appearance of the skin
WO2022160019A1 (en) 2021-01-29 2022-08-04 L'oreal Tinted cosmetic sunscreen composition, use of a tinted cosmetic sunscreen composition, and process for manufacturing a tinted cosmetic sunscreen composition
WO2022160021A1 (en) 2021-01-29 2022-08-04 L'oreal Cosmetic composition for providing dark color shades, use of a cosmetic composition for providing dark color shades and processes for manufacturing a cosmetic composition for providing dark color shades
WO2022160020A1 (en) 2021-01-29 2022-08-04 L'oreal Water-in-oil cosmetic sunscreen composition, use of a water-in-oil cosmetic sunscreen composition, and process for manufacturing a water-in-oil cosmetic sunscreen composition
FR3119988A1 (en) 2021-02-25 2022-08-26 L'oreal Aqueous composition comprising an organic UV filter, a superabsorbent polymer, perlite and a fatty alcohol
WO2022221930A1 (en) 2021-04-23 2022-10-27 L'oreal Cosmetic sunscreen composition, use of a cosmetic sunscreen composition, and process for manufacturing a cosmetic sunscreen composition
WO2022234092A1 (en) 2021-05-07 2022-11-10 L'oreal Oil-in-water emulsion comprising a particular mixture of surfactants and the combination of at least one starch grafted with an acrylic polymer and of at least one starch not grafted with an acrylic polymer
FR3124698A1 (en) 2021-06-30 2023-01-06 L'oreal Composition comprising at least one UV screening agent, boron nitride, and a nonionic surfactant of ester type
WO2023110777A1 (en) 2021-12-17 2023-06-22 L'oreal Cosmetic or dermatological composition comprising a merocyanine and pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate
WO2023110815A1 (en) 2021-12-13 2023-06-22 L'oreal Emulsion with alpha-hydroxy acid, uv filter and polymer
WO2023110770A1 (en) 2021-12-17 2023-06-22 L'oreal Cosmetic or dermatological composition comprising a merocyanine and dipropylene glycol
WO2023110773A1 (en) 2021-12-17 2023-06-22 L'oreal Cosmetic or dermatological composition comprising a merocyanine and at least one diol comprising from 4 to 7 carbon atoms
WO2023110772A1 (en) 2021-12-17 2023-06-22 L'oreal Cosmetic or dermatological composition comprising at least a merocyanine and a hydrotrope
WO2023110767A1 (en) 2021-12-17 2023-06-22 L'oreal Cosmetic or dermatological composition comprising a merocyanine and a gamma-butyrolactone and/or a gamma-butyrolactam
WO2023110764A1 (en) 2021-12-17 2023-06-22 L'oreal Cosmetic or dermatological composition comprising a merocyanine and resveratrol and/or a resveratrol derivative
WO2023110763A1 (en) 2021-12-17 2023-06-22 L'oreal Cosmetic and/or dermatological composition comprising at least one merocyanine and at least ascorbic acid and/or a derivative thereof
FR3130605A1 (en) 2021-12-21 2023-06-23 L'oreal Cosmetic composition comprising a particulate cellulosic compound, hydrophobic silica airgel particles, and a semi-crystalline polymer
FR3130606A1 (en) 2021-12-21 2023-06-23 L'oreal Cosmetic composition comprising a particulate cellulosic compound, particles of hydrophobic silica airgel, and a wax of plant origin
FR3130565A1 (en) 2021-12-20 2023-06-23 L'oreal Use of bismuth oxycarbonate particles for the filtration of ultraviolet radiation
FR3130599A1 (en) 2021-12-17 2023-06-23 L'oreal Cosmetic or dermatological composition comprising a merocyanin and a gamma-butyrolactone and/or a gamma-butyrolactam
FR3130608A1 (en) 2021-12-21 2023-06-23 L'oreal Cosmetic composition comprising a particulate cellulosic compound, hydrophobic silica airgel particles, a semi-crystalline polymer and a wax of plant origin
WO2023126397A1 (en) 2021-12-31 2023-07-06 L'oreal Kit for customizing a cosmetic composition
FR3131694A1 (en) 2022-01-11 2023-07-14 L'oreal Emulsion with alpha-hydroxy acid, UV filter and polymer
FR3132637A1 (en) 2022-02-15 2023-08-18 L'oreal Cosmetic or dermatological composition comprising a merocyanine and a polyionic complex
WO2023170236A1 (en) 2022-03-10 2023-09-14 L'oreal Composition comprising at least one amps® copolymer, at least one alkyl(poly)glycoside, at least one uv-screening agent and isopropyl myristate
WO2023198923A1 (en) 2022-04-15 2023-10-19 L'oreal Direct emulsion comprising a uv-screening agent, a lipophilic acrylic polymer, a fatty acid ester of a polyol and a carboxylic anionic surfactant
WO2023235942A1 (en) 2022-06-10 2023-12-14 L'oreal Cosmetic sunscreen composition and use of a cosmetic sunscreen composition

Cited By (227)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002049595A3 (en) * 2000-12-18 2003-10-09 Oreal Filtering composition containing a filter of the type derived from dibenzoylmethane and a 4,4-diarylbutadiene type filter
FR2818145A1 (en) * 2000-12-18 2002-06-21 Oreal ANTISOLAR COSMETIC COMPOSITIONS BASED ON A SYNERGETIC MIXTURE OF FILTERS AND USES
FR2818144A1 (en) * 2000-12-18 2002-06-21 Oreal Photoprotective cosmetic or dermatological composition comprises a bis-resorcinyl triazine filter and a 4,4-diarylbutadiene filter
WO2002049599A3 (en) * 2000-12-18 2003-10-09 Oreal Filtering composition containing a 1,3,5-triazine derivative, a dibenzoylmethane derivative, and a 4,4-diarylbutadiene compound
FR2818129A1 (en) * 2000-12-18 2002-06-21 Oreal PHOTOSTABLE FILTERING COMPOSITION CONTAINING UV FILTER DERIVED FROM DIBENZOYLMETHANE, P-METHYL-BENZYLIDENE CAMPHOR AND 4,4-DIARYLBUTADIENE COMPOUND
WO2002049598A3 (en) * 2000-12-18 2003-10-09 Oreal Cosmetic solar protection compositions based on a synergic mixture of filters and uses
FR2818126A1 (en) * 2000-12-18 2002-06-21 Oreal PHOTOSTABLE FILTERING COMPOSITION CONTAINING A 1,3,5-TRIZAZINE DERIVATIVE, A DIBENZOYLMETHANE DERIVATIVE AND A 4,4-DIARYLBUTADIENE COMPOUND
FR2818127A1 (en) * 2000-12-18 2002-06-21 Oreal PHOTOSTABLE FILTERING COMPOSITION CONTAINING A DIBENZOYLMETHANE-DERIVED TYPE FILTER AND A 4,4-DIARYLBUTADIENE COMPOUND
FR2818143A1 (en) * 2000-12-18 2002-06-21 Oreal Photoprotective cosmetic or dermatological composition useful for e.g. a sunscreen, comprises a benzotriazole-functional silicon-containing filter and a 4,4-diarylbutadiene filter
WO2002049594A2 (en) * 2000-12-18 2002-06-27 L'oreal Cosmetic sunscreen compositions based on a synergic mixture of filters and uses
WO2002049599A2 (en) * 2000-12-18 2002-06-27 L'oreal Filtering composition containing a 1,3,5-triazine derivative, a dibenzoylmethane derivative, and a 4,4-diarylbutadiene compound
WO2002049595A2 (en) * 2000-12-18 2002-06-27 L'oreal Filtering composition containing a filter of the type derived from dibenzoylmethane and a 4,4-diarylbutadiene type filter
WO2002049597A2 (en) 2000-12-18 2002-06-27 L'oreal Cosmetic solar protection compositions based on a synergic mixture of filters and uses
WO2002049596A2 (en) * 2000-12-18 2002-06-27 L'oreal Filtering composition containing a filter of the type derived from dibenzoylmethane, p-methyl-benzylidene camphor and a diarylbutadiene compound
WO2002049598A2 (en) * 2000-12-18 2002-06-27 L'oreal Cosmetic solar protection compositions based on a synergic mixture of filters and uses
WO2002049596A3 (en) * 2000-12-18 2003-09-04 Oreal Filtering composition containing a filter of the type derived from dibenzoylmethane, p-methyl-benzylidene camphor and a diarylbutadiene compound
FR2818130A1 (en) * 2000-12-18 2002-06-21 Oreal ANTISOLAR COSMETIC COMPOSITIONS BASED ON A SYNERGETIC MIXTURE OF FILTERS AND USES
FR2818128A1 (en) * 2000-12-18 2002-06-21 Oreal ANTISOLAR COSMETIC COMPOSITIONS BASED ON A SYNERGETIC MIXTURE OF FILTERS AND USES
FR2818142A1 (en) * 2000-12-18 2002-06-21 Oreal Photoprotective cosmetic or dermatological composition useful as e.g. a sunscreen, comprises a filter with at least one or two benzazole groups and a 4,4-diarylbutadiene filter
WO2002049594A3 (en) * 2000-12-18 2003-10-09 Oreal Cosmetic sunscreen compositions based on a synergic mixture of filters and uses
WO2002049597A3 (en) * 2000-12-18 2003-10-09 Oreal Cosmetic solar protection compositions based on a synergic mixture of filters and uses
US6994844B2 (en) 2000-12-18 2006-02-07 L'oreal Photostable UV-screening compositions comprising dibenzoylmethane/diarylbutadiene compounds
US7166274B2 (en) 2000-12-18 2007-01-23 L'oreal Synergistically high SPF photoprotective UV-screening compositions comprising insoluble organic sunscreen particles/diarylbutadiene compounds
EP2196189A1 (en) 2001-12-07 2010-06-16 L'oreal Cosmetic sunscreen compositions based on synergistic filter mixture and their use
US7378103B2 (en) 2004-03-22 2008-05-27 L'oreal Cosmetic composition comprising a polyglycerolated silicone elastomer
EP1618870A1 (en) 2004-07-02 2006-01-25 L'oreal Process for photostabilising a dibenzoylmethane derivative with an arylalkyl benzoate derivative and sunscreening cosmetic compositions
EP1674069A1 (en) 2004-12-17 2006-06-28 L'oreal Cosmetic method for performing skin care and kit therefor
EP1671680A1 (en) 2004-12-20 2006-06-21 L'oreal Self-tanning composition having two components, multicompartment device and process for colouring the skin
EP1688127A1 (en) 2005-01-18 2006-08-09 L'oreal Hair treatment composition containing an aromatic alcohol, an aromatic carboxylic acid a protecting agent
US8790623B2 (en) 2005-01-18 2014-07-29 Il'Oreal Composition for treating keratin fibers, comprising at least one aromatic alcohol, at least one aromatic carboxylic acid, and at least one protecting agent
EP1705187A1 (en) 2005-03-18 2006-09-27 L'oreal Cosmetic compositions comprising KAP-polypeptides for care, strengthening, and/or repair of substrates consisting of keratin
US9308155B2 (en) 2005-07-13 2016-04-12 L'oreal Photoprotective composition and screening agents for said composition
EP1997473A2 (en) 2007-04-30 2008-12-03 L'Oreal Use of a multi-carbosite, multi-group coupling agent for protecting the colour of artificially dyed keratin fibres with respect to washing; dyeing processes
EP2011481A2 (en) 2007-07-06 2009-01-07 L'Oreal Sun-protection composition containing the association of a semi-crystalline polymer and hollow latex particles
EP2016932A2 (en) 2007-07-09 2009-01-21 L'Oréal Use of dehydroascorbic acid or its polymer derivatives for skin colouring; care and/or make-up methods
EP2014277A1 (en) 2007-07-12 2009-01-14 L'Oreal Aqueous liquid photoprotective composition based on a polyamide polymer with tertiary amide termination
EP2100585A1 (en) 2008-03-11 2009-09-16 L'Oréal Cosmetic composition comprising an ascorbic acid or salicylic acid compound
EP2100586A1 (en) 2008-03-11 2009-09-16 L'Oréal Cosmetic composition comprising an ascorbic acid or salicylic acid compound
EP2119429A1 (en) 2008-05-14 2009-11-18 L'Oréal Cosmetic composition containing a dibenzoylmethane derivative and a pyrrolidinone derivative; method for photostabilising the dibenzoylmethane derivative
EP2168567A1 (en) 2008-09-24 2010-03-31 L'Oréal Uses of dithiolane compounds for the photoprotection of the skin, dithiolane compounds and compositions containing same
EP2174644A1 (en) 2008-10-08 2010-04-14 L'oreal Cosmetic composition comprising a dibenzoylmethane derivative and a dithiolane; Photostabilization of a dibenzoylmethane derivative
EP2191869A1 (en) 2008-12-01 2010-06-02 L'oreal Method for artificially colouring the skin using a mixture of carotenoid and of lipophilic green dye; novel mixture of lipophilic dyes; composition
EP2193784A1 (en) 2008-12-08 2010-06-09 L'oreal Cosmetic compositions containing an ester derivative of 2-pyrrolidinone 4-carboxy and a lipophilic triazine filter, with use of said derivative as a solvent of a lipophilic triazine filter
EP2193782A1 (en) 2008-12-08 2010-06-09 L'Oreal Cosmetic composition comprising a dibenzoylmethane derivative and a 2-pyrrolidinone-4-carboxy ester compound; method for the photostabilization of the dibenzoylmethane derivative
EP2198837A1 (en) 2008-12-22 2010-06-23 L'oreal Cosmetic composition containing four surfactants, a cationic polymer and a zinc salt
EP2204165A1 (en) 2008-12-30 2010-07-07 L'oreal Combination of monosaccharides with solar filters and cosmetic use thereof
WO2011004133A2 (en) 2009-07-10 2011-01-13 L'oreal Composite material comprising uv filters and plasmonic particles, and use as sun screen
WO2011023886A2 (en) 2009-08-28 2011-03-03 L'oreal Composition containing at least one lipophilic 2-hydroxybenzophenone filter and a silicon s-triazine substituted by at least two alkylaminobenzoate groups
EP2301518A2 (en) 2009-08-28 2011-03-30 L'Oréal Cosmetic composition including a hydroxylated diphenyl-methane derivative
WO2011042358A1 (en) 2009-10-08 2011-04-14 L'oreal Photoprotective composition based on a 2-alkoxy-4-alkyl ketone phenol compound; use of said compound for increasing the sun protection factor
EP3281620A1 (en) 2009-10-08 2018-02-14 L'oreal Photoprotective composition based on a 2-alkoxy-4-alkyl ketone phenol compound; use of said compound for increasing the sun protection factor
WO2011045746A2 (en) 2009-10-12 2011-04-21 L ' Oreal A composition comprising a dispersion of photonic particles; methods of treating various materials
WO2011045740A2 (en) 2009-10-12 2011-04-21 L'oreal Methods of photoprotecting a material against solar uv radiation using photonic particles; compositions
WO2011045741A2 (en) 2009-10-12 2011-04-21 L'oreal Photonic particles; compositions containing them; methods of photoprotecting various materials
US8241615B2 (en) 2009-10-19 2012-08-14 L'oreal S.A. Water-resistant sunscreen composition
US9381383B2 (en) 2009-10-22 2016-07-05 L'oreal Photoprotective compositions and films, and a preparation method
WO2011073280A2 (en) 2009-12-18 2011-06-23 L'oreal Cosmetic treatment method involving a durable compound capable of condensing in situ
WO2011073279A2 (en) 2009-12-18 2011-06-23 L'oreal Cosmetic treatment method involving a compound capable of condensing in situ
WO2011074141A1 (en) 2009-12-18 2011-06-23 L'oreal Process for treating keratin fibers
WO2011073578A2 (en) 2009-12-18 2011-06-23 L'oreal Cosmetic treatment method using a compound that can be condensed in situ and a uv-radiation-filtering agent
WO2011073576A2 (en) 2009-12-18 2011-06-23 L'oreal Skin-colouring method using a compound that can be condensed in situ and a skin-colouring agent
WO2011080043A1 (en) 2010-01-04 2011-07-07 L'oreal Ureidopyrimidones; cosmetic use as uv-screening agents; antisun compositions containing them
WO2011113718A1 (en) 2010-03-15 2011-09-22 L'oreal Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent
WO2011113719A2 (en) 2010-03-15 2011-09-22 L'oreal Composition comprising a dibenzoylmethane screening agent and a merocyanine dicyano or cyanoacetate derivative; method for the photostabilization of the dibenzoylmethane screening agent
WO2011151203A2 (en) 2010-06-03 2011-12-08 L'oreal Cosmetic treatment process using a coating based on a copolymer containing polyamide blocks and polyether blocks
WO2011157746A1 (en) 2010-06-16 2011-12-22 L'oreal Cosmetic antioxidant aromatic c-glycosides
WO2012010554A1 (en) 2010-07-20 2012-01-26 L'oreal Use of compounds resulting from a sugar polyol or from a dehydrogenated sugar polyol derivative as a uv-screening agent; antisun compositions containing same; and novel compounds
WO2012059348A1 (en) 2010-11-05 2012-05-10 L'oreal Fluid aqueous antisun composition based on a superabsorbent polymer and a crosslinked copolymer of methacrylic acid and of a c1-c4 alkyl acrylate
WO2012119860A1 (en) 2011-03-09 2012-09-13 L'oreal Cosmetic composition containing a dibenzoylmethane derivative and a monoester-monoamide compound of methylsuccinic acid; process for photostabilizing a dibenzoylmethane derivative
WO2012160289A2 (en) 2011-05-20 2012-11-29 L'oreal Cosmetic composition comprising a superabsorbent polymer and a carbohydrate chosen from monosaccharides, oligosaccharides and homopolysaccharides
WO2012172057A2 (en) 2011-06-16 2012-12-20 L'oreal Use of a compound comprising at least one nucleophilic function for capturing carbonyl compounds resulting from the reaction between one or more compounds constituting sebum and ozone
WO2013004777A1 (en) 2011-07-07 2013-01-10 L'oreal Photoprotective composition
WO2013010590A1 (en) 2011-07-21 2013-01-24 L'oreal Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities
WO2013011094A2 (en) 2011-07-21 2013-01-24 L'oreal Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities
WO2013068237A1 (en) 2011-11-07 2013-05-16 L'oreal Composition with a continuous oil phase containing at least one lipophilic organic uv-screening agent and hydrophobic silica aerogel particles
US8454942B1 (en) 2011-11-29 2013-06-04 L'oreal Cosmetic oil mousse composition
WO2013080127A2 (en) 2011-11-29 2013-06-06 L'oreal Cosmetic oil mousse composition
WO2013080140A2 (en) 2011-12-02 2013-06-06 L'oreal Sunscreen compositions containing a novel preservative system
WO2013117449A1 (en) 2012-02-06 2013-08-15 L'oreal Non-pulverulent antisun composition comprising a polar oil phase and hydrophobic silica aerogel particles
WO2014006589A2 (en) 2012-07-04 2014-01-09 L'oreal Photoprotective cosmetic composition
WO2014009097A1 (en) 2012-07-13 2014-01-16 L'oreal Cosmetic composition containing screening composite particles
US10888504B2 (en) 2012-10-15 2021-01-12 L'oreal Hair styling compositions containing aqueous wax dispersions
US9408785B2 (en) 2012-10-15 2016-08-09 L'oreal Hair styling compositions containing aqueous wax dispersions
US10626294B2 (en) 2012-10-15 2020-04-21 L'oreal Aqueous wax dispersions containing volatile solvents
US10413496B2 (en) 2012-10-15 2019-09-17 L'oreal Aqueous wax dispersions
WO2014060405A2 (en) 2012-10-15 2014-04-24 L'oreal Aqueous wax dispersions and hair styling compositions containing them
WO2014105877A1 (en) 2012-12-27 2014-07-03 L'oreal Low viscosity meta-stable photoprotection composition
WO2014111563A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and a lipophilic benzotriazole uv-screening agent and/or a bis-resorcinyl triazine compound
WO2014111565A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological emulsion comprising a merocyanine and an emulsifying system containing a gemini surfactant
WO2014111564A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine, an oily phase and a c1-c4 monoalkanol
WO2014111566A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an insoluble organic uv-screening agent and/or an insoluble inorganic uv- screening agent
WO2014111571A1 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological emulsion comprising a merocyanine and an emulsifying system containing an amphiphilic polymer comprising at least one 2-acrylamidomethylpropanesulfonic acid unit
WO2014111568A1 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological water-in-oil emulsion comprising a merocyanine and at least one emulsifying polymer of the polyoxyalkylenated glycol fatty acid ester type
WO2014111570A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one specific amide compound
WO2014111562A1 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological emulsion comprising a merocyanine and an emulsifying system containing an alkali metal salt of a phosphoric acid ester of a fatty alcohol
WO2014111567A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and a uva-screening agent of the amino-substituted 2-hydroxybenzophenone type and/or a hydrophilic organic uva-screening agent
WO2014111569A2 (en) 2013-01-21 2014-07-24 L'oreal Anhydrous cosmetic or dermatological composition comprising a merocyanine and an oily phase
WO2014167225A1 (en) 2013-04-08 2014-10-16 Universite De Rennes 1 Photoprotective compounds, compositions including same and uses thereof
WO2014191324A1 (en) 2013-05-29 2014-12-04 L'oreal Composite particles based on mineral uv-screening agent and perlite; cosmetic or dermatological compositions containing the same
WO2014192780A1 (en) 2013-05-30 2014-12-04 L'oreal Cosmetic composition
WO2015089035A1 (en) 2013-12-09 2015-06-18 Momentive Performance Materials Inc. Emulsion compositions and applications therefor
US9579276B2 (en) 2013-12-12 2017-02-28 L'oreal Clear sunscreen composition for application onto wet or dry skin
WO2015140472A1 (en) 2014-03-19 2015-09-24 L'oreal Cosmetic composition comprising beneficial agents for keratin materials, and a mixture of sulfonate-containing derivatives of olefins, and cosmetic treatment method
US10561596B2 (en) 2014-04-11 2020-02-18 L'oreal Compositions and dispersions containing particles comprising a polymer
US10172783B2 (en) 2014-06-04 2019-01-08 L'oreal High UV protection alcohol-free anhydrous clear system
WO2015186078A1 (en) 2014-06-04 2015-12-10 L'oreal High uv protection alcohol-free anydrous clear system
WO2016030839A1 (en) 2014-08-28 2016-03-03 L'oreal Gel composition and gel comprising a uv filter
WO2016050778A1 (en) 2014-09-30 2016-04-07 L'oreal High uv protection alcohol-free emulsion system, that is clear on application
US9820920B2 (en) 2014-09-30 2017-11-21 L'oreal High UV protection alcohol-free emulsion system, that is clear on application
WO2016083404A1 (en) 2014-11-24 2016-06-02 L'oreal Cosmetic composition comprising a synthetic phyllosilicate and a polyol and/or a uv filter
US11382855B2 (en) 2014-12-18 2022-07-12 L'oreal Compositions and methods for improving the appearance of the skin
WO2016119028A1 (en) 2015-01-29 2016-08-04 L'oreal Transparent sunscreen composition
WO2016198581A1 (en) 2015-06-11 2016-12-15 L'oreal Composition comprising a uv-screening agent, an anionic crosslinked hydrophilic polymer, a surfactant having an hlb less than or equal to 5 and a silicone copolymer
WO2016204947A1 (en) 2015-06-19 2016-12-22 L'oreal Sunscreen composition containing high levels of liposoluble uv filters
WO2016204946A1 (en) 2015-06-19 2016-12-22 L'oreal Water-in-oil sunscreen composition having organic sunscreen actives
WO2017000050A1 (en) 2015-06-29 2017-01-05 L'oreal Oil controlling sunscreen composition
WO2016203062A1 (en) 2015-09-25 2016-12-22 Rhodia Operations Cosmetic photoprotection composition
US11191710B2 (en) 2015-12-23 2021-12-07 L'oreal Photoprotective cosmetic composition and process for obtaining the same
US10835479B2 (en) 2015-12-31 2020-11-17 L'oreal Systems and methods for improving the appearance of the skin
US10292922B2 (en) 2015-12-31 2019-05-21 L'oreal Silicone-wax dispersion compositions for removing cosmetic films
WO2017129669A1 (en) 2016-01-26 2017-08-03 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one isosorbide ether
WO2017129670A1 (en) 2016-01-26 2017-08-03 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one n-substituted amide
EP3827807A1 (en) 2016-01-26 2021-06-02 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one n-substituted amide
WO2017129673A1 (en) 2016-01-26 2017-08-03 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one di- or tricarboxylic acid ester
WO2017129674A1 (en) 2016-01-26 2017-08-03 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one polyalkylene glycol.
WO2017189301A1 (en) 2016-04-29 2017-11-02 L'oreal Uv-a/uv-b sunscreen composition
WO2018115360A1 (en) 2016-12-21 2018-06-28 L'oreal Composition comprising baicalin, a fatty acid ester and an alkylpolyglycoside
WO2018115493A1 (en) 2016-12-23 2018-06-28 L'oreal Composition comprising baicalin
WO2018159139A1 (en) 2017-02-28 2018-09-07 L'oreal Composition comprising resorcinol or derivative thereof
WO2018206764A1 (en) 2017-05-12 2018-11-15 L'oreal Photostable composition made from perlite/titanium/silica composite particles
WO2019002495A1 (en) 2017-06-29 2019-01-03 L'oreal Photoprotective compositions comprising a dibenzoylmethane derivative, a merocyanine compound and a compound capable of accepting the triplet excited level energy of the dibenzoylmethane compound
WO2019096953A1 (en) 2017-11-15 2019-05-23 L'oreal Cosmetic emulsion containing a gemini surfactant and a lipophilic polymer
WO2019096956A1 (en) 2017-11-15 2019-05-23 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an acrylic polymer
WO2019102114A1 (en) 2017-11-24 2019-05-31 Rhodia Operations Cerium oxide/silica particles
WO2019119077A1 (en) 2017-12-19 2019-06-27 L'oreal Sun care composition
WO2019119078A1 (en) 2017-12-19 2019-06-27 L'oreal Sun care composition
WO2019121636A1 (en) 2017-12-19 2019-06-27 L'oreal Composition comprising baicalin and an antioxidant compound
WO2019209483A1 (en) 2018-04-23 2019-10-31 L'oreal Memory-shape sunscreen composition
US10813875B2 (en) 2018-04-23 2020-10-27 L'oreal Memory shape sunscreen composition
WO2019210376A1 (en) 2018-04-30 2019-11-07 L'oreal Sunscreen compositions
WO2020002537A1 (en) 2018-06-28 2020-01-02 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one alkyl or alkylene carbonate
WO2020000068A1 (en) 2018-06-28 2020-01-02 L'oreal Surfactant system and sunscreen composition comprising it
WO2020024022A1 (en) 2018-07-31 2020-02-06 L'oreal Sun care composition for whitening the skin, use of the sun care composition, and process of manufacture of the sun care composition
WO2020024023A1 (en) 2018-07-31 2020-02-06 L'oreal Sunscreen composition, use of the sunscreen composition and process of manufacturing the sunscreen composition
FR3090359A1 (en) 2018-12-20 2020-06-26 L'oreal Cosmetic treatment process comprising the generation of a foam from two anhydrous compositions
WO2020127760A1 (en) 2018-12-20 2020-06-25 L'oreal Cosmetic treatment process comprising the generation of a foam from two anhydrous compositions
FR3090337A1 (en) 2018-12-21 2020-06-26 L'oreal FLUID PHOTOPROCTOR COMPOSITION
FR3090329A1 (en) 2018-12-21 2020-06-26 L'oreal Composition comprising a UV filter, an anionic crosslinked hydrophilic polymer, a surfactant having an HLB less than or equal to 5 and a non-volatile alkane
WO2020127100A1 (en) 2018-12-21 2020-06-25 L'oreal Fluid photoprotective composition
WO2020163928A1 (en) 2019-02-13 2020-08-20 L'oreal Sunscreen composition, use of the sunscreen composition and process of manufacturing the sunscreen composition
WO2020172726A1 (en) 2019-02-28 2020-09-03 L'oreal Anti-acne sunscreen composition, process for manufacturing an anti-acne sunscreen composition and use of an anti-acne sunscreen composition
WO2020172725A1 (en) 2019-02-28 2020-09-03 L'oreal Sunscreen composition, use of a sunscreen composition, use of the liquid carnauba wax and process of manufacturing a sunscreen composition
WO2021016684A1 (en) 2019-07-31 2021-02-04 L'oreal Cosmetic composition, process for manufacturing the cosmetic composition and its use
FR3103704A1 (en) 2019-11-29 2021-06-04 L'oreal Composition comprising a UV filter, an ethylenic polymer with a phosphonic acid group and a hydrocarbon oil
FR3103705A1 (en) 2019-11-29 2021-06-04 L'oreal A composition comprising a UV filter, a block polymer containing a phosphonic acid group and a hydrocarbon oil
WO2021123337A1 (en) 2019-12-20 2021-06-24 L'oreal Retinol-based composition
WO2021123233A1 (en) 2019-12-20 2021-06-24 L'oreal Retinol-based composition
FR3104975A1 (en) 2019-12-20 2021-06-25 L'oreal Retinol-based composition
FR3104976A1 (en) 2019-12-20 2021-06-25 L'oreal Retinol-based composition
WO2021250008A1 (en) 2020-06-08 2021-12-16 L'oreal Retinol-based composition
WO2021250001A1 (en) 2020-06-08 2021-12-16 L'oreal Retinol-based composition
FR3111074A1 (en) 2020-06-08 2021-12-10 L'oreal Retinol-based composition
FR3111075A1 (en) 2020-06-08 2021-12-10 L'oreal Retinol-based composition
FR3111809A1 (en) 2020-06-30 2021-12-31 L'oreal Photoprotective cosmetic composition, use of a photoprotective cosmetic composition and process for the manufacture of a photoprotective cosmetic composition
WO2022000053A1 (en) 2020-06-30 2022-01-06 L'oreal Cosmetic sunscreen composition, use of a cosmetic sunscreen composition, and processes for manufacturing a cosmetic sunscreen composition
WO2022084458A1 (en) 2020-10-23 2022-04-28 L'oreal Photoprotective composition
FR3115457A1 (en) 2020-10-23 2022-04-29 L'oreal Photoprotective composition
FR3115991A1 (en) 2020-11-06 2022-05-13 L'oreal Solid anhydrous composition comprising a lipophilic organic UV filter, a hydrocarbon oil, and at least 10% of a high melting point wax
WO2022129039A1 (en) 2020-12-18 2022-06-23 L'oreal Cosmetic composition comprising a merocyanine, a triazine uv-screening agent, and a polysaccharide modified with hydrophobic chains
WO2022129059A1 (en) 2020-12-18 2022-06-23 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one citric acid ester
FR3117824A1 (en) 2020-12-18 2022-06-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one citric acid ester
FR3117825A1 (en) 2020-12-18 2022-06-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine, a triazine UV filter, and a polysaccharide modified by hydrophobic chains
FR3117855A1 (en) 2020-12-23 2022-06-24 L'oreal : Cosmetic composition comprising a copolymer based on acetoacetate functions
FR3117794A1 (en) 2020-12-23 2022-06-24 L'oreal Aqueous dispersion of a specific copolymer and its cosmetic applications
FR3117788A1 (en) 2020-12-23 2022-06-24 L'oreal Aqueous dispersion of a specific copolymer and its cosmetic applications
FR3117852A1 (en) 2020-12-23 2022-06-24 L'oréal Cosmetic composition comprising a copolymer based on acetoacetate functions
FR3117854A1 (en) 2020-12-23 2022-06-24 L'oréal Cosmetic composition comprising polymeric particles based on acetoacetate functions
FR3117856A1 (en) 2020-12-23 2022-06-24 L'oréal Cosmetic composition comprising a block copolymer based on acetoacetate functions
WO2022136110A1 (en) 2020-12-23 2022-06-30 L'oreal Cosmetic composition comprising polymer particles based on acetoacetate functions
WO2022136104A1 (en) 2020-12-23 2022-06-30 L'oreal Cosmetic composition comprising a copolymer based on acetoacetate functions
WO2022136114A1 (en) 2020-12-23 2022-06-30 L'oreal Aqueous dispersion of a specific copolymer, and cosmetic uses thereof
FR3117853A1 (en) 2020-12-23 2022-06-24 L'oreal Cosmetic composition comprising polymeric particles based on acetoacetate functions
WO2022160021A1 (en) 2021-01-29 2022-08-04 L'oreal Cosmetic composition for providing dark color shades, use of a cosmetic composition for providing dark color shades and processes for manufacturing a cosmetic composition for providing dark color shades
WO2022160020A1 (en) 2021-01-29 2022-08-04 L'oreal Water-in-oil cosmetic sunscreen composition, use of a water-in-oil cosmetic sunscreen composition, and process for manufacturing a water-in-oil cosmetic sunscreen composition
FR3119322A1 (en) 2021-01-29 2022-08-05 L'oreal Tinted cosmetic sunscreen composition, use of tinted cosmetic sunscreen composition, and process for making tinted cosmetic sunscreen composition
FR3119318A1 (en) 2021-01-29 2022-08-05 L'oreal COSMETIC COMPOSITION FOR PROVIDING DARK COLOR TINTS, ITS USE AND METHODS OF MAKING IT
FR3119316A1 (en) 2021-01-29 2022-08-05 L'oreal COSMETIC WATER-IN-OIL SUNSCREEN COMPOSITION, USE OF A COSMETIC WATER-IN-OIL SUNSCREEN COMPOSITION, AND METHOD FOR MAKING A COSMETIC WATER-IN-OIL SUNSCREEN COMPOSITION
WO2022160019A1 (en) 2021-01-29 2022-08-04 L'oreal Tinted cosmetic sunscreen composition, use of a tinted cosmetic sunscreen composition, and process for manufacturing a tinted cosmetic sunscreen composition
FR3119988A1 (en) 2021-02-25 2022-08-26 L'oreal Aqueous composition comprising an organic UV filter, a superabsorbent polymer, perlite and a fatty alcohol
WO2022180010A2 (en) 2021-02-25 2022-09-01 L'oreal Composition comprising an organic uv-screening agent, a superabsorbant polymer, perlite and a fatty alcohol
WO2022221930A1 (en) 2021-04-23 2022-10-27 L'oreal Cosmetic sunscreen composition, use of a cosmetic sunscreen composition, and process for manufacturing a cosmetic sunscreen composition
WO2022234092A1 (en) 2021-05-07 2022-11-10 L'oreal Oil-in-water emulsion comprising a particular mixture of surfactants and the combination of at least one starch grafted with an acrylic polymer and of at least one starch not grafted with an acrylic polymer
FR3122578A1 (en) 2021-05-07 2022-11-11 L'oreal Cosmetic composition in the form of an oil-in-water emulsion comprising a particular mixture of surfactants and the combination of at least one starch grafted with an acrylic polymer and at least one starch not grafted with an acrylic polymer
FR3124698A1 (en) 2021-06-30 2023-01-06 L'oreal Composition comprising at least one UV screening agent, boron nitride, and a nonionic surfactant of ester type
WO2023110815A1 (en) 2021-12-13 2023-06-22 L'oreal Emulsion with alpha-hydroxy acid, uv filter and polymer
WO2023110767A1 (en) 2021-12-17 2023-06-22 L'oreal Cosmetic or dermatological composition comprising a merocyanine and a gamma-butyrolactone and/or a gamma-butyrolactam
FR3130594A1 (en) 2021-12-17 2023-06-23 L'oreal Cosmetic or dermatological composition comprising a merocyanine and resveratrol and/or a resveratrol derivative
WO2023110773A1 (en) 2021-12-17 2023-06-22 L'oreal Cosmetic or dermatological composition comprising a merocyanine and at least one diol comprising from 4 to 7 carbon atoms
WO2023110772A1 (en) 2021-12-17 2023-06-22 L'oreal Cosmetic or dermatological composition comprising at least a merocyanine and a hydrotrope
WO2023110777A1 (en) 2021-12-17 2023-06-22 L'oreal Cosmetic or dermatological composition comprising a merocyanine and pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate
WO2023110764A1 (en) 2021-12-17 2023-06-22 L'oreal Cosmetic or dermatological composition comprising a merocyanine and resveratrol and/or a resveratrol derivative
WO2023110763A1 (en) 2021-12-17 2023-06-22 L'oreal Cosmetic and/or dermatological composition comprising at least one merocyanine and at least ascorbic acid and/or a derivative thereof
FR3130596A1 (en) 2021-12-17 2023-06-23 L'oreal Cosmetic and/or dermatological composition comprising at least one merocyanine and at least ascorbic acid and/or one of its derivatives
FR3130595A1 (en) 2021-12-17 2023-06-23 L'oreal Cosmetic or dermatological composition comprising at least one merocyanine and one hydrotrope
FR3130599A1 (en) 2021-12-17 2023-06-23 L'oreal Cosmetic or dermatological composition comprising a merocyanin and a gamma-butyrolactone and/or a gamma-butyrolactam
FR3130598A1 (en) 2021-12-17 2023-06-23 L'oreal Cosmetic or dermatological composition comprising a merocyanine and di-t-butyl pentaerythrityl tetra hydroxycinnamate
FR3130597A1 (en) 2021-12-17 2023-06-23 L'oreal Cosmetic or dermatological composition comprising a merocyanine and at least one diol comprising from 4 to 7 carbon atoms
WO2023110770A1 (en) 2021-12-17 2023-06-22 L'oreal Cosmetic or dermatological composition comprising a merocyanine and dipropylene glycol
FR3130593A1 (en) 2021-12-17 2023-06-23 L'oreal Cosmetic or dermatological composition comprising a merocyanine and dipropylene glycol
FR3130565A1 (en) 2021-12-20 2023-06-23 L'oreal Use of bismuth oxycarbonate particles for the filtration of ultraviolet radiation
WO2023117902A1 (en) 2021-12-20 2023-06-29 L'oreal Use of bismuth oxycarbonate particles for filtering ultraviolet radiation
FR3130606A1 (en) 2021-12-21 2023-06-23 L'oreal Cosmetic composition comprising a particulate cellulosic compound, particles of hydrophobic silica airgel, and a wax of plant origin
FR3130605A1 (en) 2021-12-21 2023-06-23 L'oreal Cosmetic composition comprising a particulate cellulosic compound, hydrophobic silica airgel particles, and a semi-crystalline polymer
FR3130608A1 (en) 2021-12-21 2023-06-23 L'oreal Cosmetic composition comprising a particulate cellulosic compound, hydrophobic silica airgel particles, a semi-crystalline polymer and a wax of plant origin
WO2023118072A1 (en) 2021-12-21 2023-06-29 L'oreal Cosmetic composition comprising a particulate cellulosic compound, hydrophobic silica aerogel particles, and a wax of plant origin
WO2023118065A1 (en) 2021-12-21 2023-06-29 L'oreal Cosmetic composition comprising a particulate cellulosic compound, hydrophobic silica aerogel particles, a semicrystalline polymer and a wax of plant origin
WO2023118067A1 (en) 2021-12-21 2023-06-29 L'oreal Cosmetic composition comprising a particulate cellulosic compound, hydrophobic silica aerogel particles, and a semicrystalline polymer
FR3131529A1 (en) 2021-12-31 2023-07-07 L'oreal Customization kit for a cosmetic composition
WO2023126397A1 (en) 2021-12-31 2023-07-06 L'oreal Kit for customizing a cosmetic composition
FR3131694A1 (en) 2022-01-11 2023-07-14 L'oreal Emulsion with alpha-hydroxy acid, UV filter and polymer
FR3132637A1 (en) 2022-02-15 2023-08-18 L'oreal Cosmetic or dermatological composition comprising a merocyanine and a polyionic complex
WO2023156298A1 (en) 2022-02-15 2023-08-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and a polyionic complex
WO2023170236A1 (en) 2022-03-10 2023-09-14 L'oreal Composition comprising at least one amps® copolymer, at least one alkyl(poly)glycoside, at least one uv-screening agent and isopropyl myristate
FR3133311A1 (en) 2022-03-10 2023-09-15 L'oreal COMPOSITION COMPRISING AT LEAST ONE AMPS® COPOLYMER, AT LEAST ONE ALKYLPOLYGLUCOSIDE, AT LEAST ONE UV FILTER AND ISOPROPYL MYRISTATE
WO2023198923A1 (en) 2022-04-15 2023-10-19 L'oreal Direct emulsion comprising a uv-screening agent, a lipophilic acrylic polymer, a fatty acid ester of a polyol and a carboxylic anionic surfactant
WO2023235942A1 (en) 2022-06-10 2023-12-14 L'oreal Cosmetic sunscreen composition and use of a cosmetic sunscreen composition
FR3136372A1 (en) 2022-06-10 2023-12-15 L'oreal COMPOSITION AND USE OF A COSMETIC SUNSCREEN COMPOSITION

Similar Documents

Publication Publication Date Title
DE19746654A1 (en) Use of 4,4-di:aryl-butadiene derivatives as photostable UV filter compounds
DE19755649A1 (en) Use of 4,4-diarylbutadienes as photostable UV filters in cosmetics
EP0916335B1 (en) Cosmetic and parmaceutical compositions containing a photostable UV filter
EP1005855B1 (en) Dimer alpha-alkyl-styrene derivatives as photostable UV-filters for cosmetic or pharmaceutical compositions
EP0967200B1 (en) 4,4-Diarylbutadienes as water soluble, photostable UV-filters for cosmetic and pharmaceutical preparations
DE19712033A1 (en) Use of enamine derivatives as ultraviolet-A filters
DE19917906A1 (en) Use of amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations
EP0852137A2 (en) Cosmetic compositions containing a photostable UV-A filter
DE10012408A1 (en) Use of sunscreen combinations which contain as essential constituent amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations
DE10012413A1 (en) Use of sunscreen combinations containing as essential constituent 4,4&#39;-diarylbutadienes as photostable UV filters in cosmetic and pharmaceutical preparations
DE19857127A1 (en) Oligomeric diarylbutadienes
DE10238144A1 (en) Use of aryl-substituted 3,6-dialkylidene-2,5-piperazinedione derivatives as photostable UV filters in cosmetic or pharmaceutical compositions for protecting human skin or hair against solar radiation
DE10113058A1 (en) Use of light stabilizer combinations which contain 2- (4-alkoxy-anilinomethylene) -malonic acid dialkyl esters as an essential constituent as photostable UV filters in cosmetic and pharmaceutical preparations
DE10063946A1 (en) Use of light stabilizer combinations which contain 2,2&#39;-p-phenylene-bis (3,1-benzoxazin-4-one) as an essential constituent as a photostable UV filter in cosmetic and pharmaceutical preparations
EP0911020B1 (en) Methylstyrene derivatives as UV-filters and cosmetic and pharmaceutical preparations containing them
EP0826361B1 (en) Cosmetical preparations containing photostable UV-A filters
EP0474063B1 (en) Dialkoxybenzylidene campher derivatives
DE3833706A1 (en) NEW T-BUTYL DERIVATIVES OF BENZYLIDENE CAMPERS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTIOXIDING AGENTS, AND AS PHARMACEUTICAL AND COSMETIC AGENTS
DE3543496A1 (en) 4-METHOXY-2&#39;-CARBOXYDIBENZOYLMETHANE AND ITS SALTS
DE19755650A1 (en) Cosmetic and pharmaceutical preparations containing photostable UV filters
EP0945125B1 (en) Cosmetic and pharmaceutical compositions containing photostable uv filters
EP0858318B1 (en) Cosmetic preparations containing photostable uv-a filters
DE19649381A1 (en) Use of cyano-((hetero)aryl-amino)-alkenone compounds as UV filters
DE10124332A1 (en) Cosmetic or pharmaceutical preparations containing enaminotriazines as light stabilizers and new enaminotriazines

Legal Events

Date Code Title Description
8130 Withdrawal